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SUMMARY 
In this thesis a detailed study of the kinetics of GnRH-
stimulated LH release was made. GnRH stimulated LH release in a 
biphasic manner. During the first 3 minutes of stimulation, there was 
a transient spike phase of release followed by plateau phase of lower 
amplitude. 
Both phases of release are largely dependent on extracellular ca2+. 
The spike phase of release is dependent on ca2+ entry via a receptor-
operated ca2+ channel (ROCC) (about 90%) and on the mobilization of 
intracellular ca2+ stores. The role of ROCC were examined by using 
ruthenium red which inhibits both ROCC and voltage-sensitive ca2+ 
channels (VSCC). VSCC are not involved in the spike phase of GnRH-
stimulated LH release since D600 and nifedipine, inhibitors of VSCC, 
have no effect on the spike phase. The plateau phase of release is 
dependent on ca2 + entry via VSCC (about 50%) and ROCC (about 50%). 
Forskolin, an activator of adenylate cyclase, was used to investigate 
the role of cAMP in LH release. Forskolin stimulated an increase in 
both LH release and cellular cAMP levels. GnRH was also able to 
elevate the cellular CAMP concentration. GnRH interacted 
synergistically with forskolin to stimulate LH release. The synergism 
between GnRH and forskolin was not due to an interaction at (1) the 
GnRH receptor, (2) the level of intracellular ca2+ mobilization, or 
(3) inositol phosphate metabolism. However, forskolin was able to 
synergistically interact with secretagogues that increase the 
cytosolic ca2+ concentration and activators of protein kinase C. This 
suggested that forskolin was interacting with GnRH at a site distal to 
the activation of the ca2+ second messenger system and protein kinase 
C. 
The data suggest that the initial response to GnRH is largely ca2+-
dependent and that other second messengers, if active, play a minor 
role. cAMP is thought to play a modulatory role and may be involved 
in the maintenance of secretion. 
1 INTRODUCTION 
Gonadotropin-releasing hormone (GnRH), a decapeptide released by 
the hypothalamus, stimulates the release of luteinizing hormone (LH) 
and follicle-stimulating hormone (FSH) from the anterior pituitary. 
1 . 2 3 4 The mammalian form of GnRH with the sequence pyro-Glu -His -Trp -Ser -
5 6 7 8 9 10 Tyr -Gly -Leu -Arg -Pro -Gly -NH2 was isolated and purified by 
Schally et al., 1971. Different molecular forms of GnRH have been 
characterised in many species, including porcine (Matsuo et al., 
1971), ovine (Amoss et al., 1971), avian (King and Millar, 1982), 
salmon Sherwood et al., 1983) and lamprey (Sherwood et al., 1986). 
Two molecular forms of GnRH have been isolated from the chicken 
hypothalamus: chicken GnRH I ([Gln8 ]GnRH) and chicken GnRH II ([His5 , 
7 8 Trp, Tyr] GnRH). Both forms of chicken GnRH stimulate the release 
of both LH and FSH (Millar and King, 1988; Millar et al., 1986), 
acting through a single GnRH receptor type in the chicken pituitary 
(King et al., 1988). It can therefore be assumed that both activate 
the same signal transduction mechanism. Chicken GnRH II is five to 
six times more potent than chicken GnRH I in stimulating LH release 
from chicken pituitary cells. Chicken GnRH I appears to be the prime 
regulator of gonadotropin release since its concentration is 180-fold 
greater than that of chicken GnRH II in the median eminence of the 
hypothalamus of chicken brain (Katz et al., 1990). The function of 
chicken GnRH II has not been clearly elucidated, but it may act as a 
neurotransmitter since it is predominantly present in the extra 
hypothalamic areas of the brain (Katz et al., 1990). 
Chicken GnRH I was used in this study because (a) I wanted to compare 
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this study to previous data obtained in our laboratory, and (b) 
unlimited stocks of chicken GnRH I was available to me. 
In this thesis the signal transduction mechanism by which chicken GnRH 
I stimulates LH release from chicken pituitary cells was investigated. 
In the literature available, it is clear that the signal transduction 
mechanism has been extensively studied in rat anterior pituitary 
cells. The signal transduction mechanism had not been well probed in 
chicken pituitary cells. This thesis addresses the questions:(1) What 
are the signal transduction mechanisms for GnRH in the chicken 
pituitary cell ? and (2) How do these differ from those in the rat 
pituitary? Aspects of GnRH-stimulated LH release which were studied 
are 2+ 2+ (1) the dependence on extracelluar Ca , (2) Ca entry routes, 
and (3) the interaction between cAMP, protein kinase C and ca2+. The 
literature review focuses on the molecular events involved in the 
mechanism of GnRH-stimulated LH release. All the studies using in 
which chicken anterior pituitary cells were used, used chicken GnRH I. 
1.1 The GnRH receptor 
GnRH binds to the GnRH receptor on the plasma membrane of 
piuitary gonadotrophs activating intracellular events that lead to the 
release of LH. The synthesis of high affinity metabolically stable 
GnRH agonist, which could easily be iodinated, facillitated the 
identification of a single class of GnRH receptors on pituitary plasma 
membranes with a Ka =1-3x1o- 10M (Marian et al., 1981). The apparent MW 
of the binding component of the GnRH receptor as determined by SDS-
polyacrylamide gel electrophoresis (SDS-PAGE) is 60 kd (Hazum 1981, 
Eidne et al., 1985). However, using target size analysis, the 
2 
functional MW of the receptor was determined to be 136 kd 
Venter, 1985). This suggests that the 60 kd protein seen on 
could be a sub-unit of the receptor. 
(Conn and 
SOS-PAGE 
Using flouresent analogues of GnRH, Naor et al. (1981) found that GnRH 
was initially evenly distribute over the cell surface of gonadotrophs 
but was localised at one pole of the cell after 20 min of incubation. 
Internalisation of the the flouresent GnRH was evident after 30 min. 
Studies using ferritin-GnRH also showed thet polar aggregation of the 
GnRH-receptor complex was observed prior to internalisation (Hopkins 
and Gregory, 1977). Following internalisation, the lysosomal and golgi 
compartments are the major sites of accumulisation of the internalised 
receptor complex (Jennes et al.,1983; Pelletier et al., 1982). 
Is internalisation of the receptor complex essential for LH release ? 
The use of an immobilized form of GnRH which was unable to be 
internalised but nevertheless still able to evoke LH release (Conn, 
Smith And Rogers, 1981) indicated that this was not the case. Also, 
vinblastin, at a dose which inhibits receptor capping and 
internalisation, did not inhibit GnRH-stimulated LH release (Gorospe 
and Conn, 1987). These results indicate that the internalisation of 
the GnRH-receptor complex can be uncoupled from the LH secretory 
response. 
1 . 2 GnRH analogues 
A large number of GnRH analogues have been made giving 
investigators much information about the structure of GnRH needed for 
it to be functionally active (Karten and Rivier, 1986). Modification 
of the C- and N-teminal amino acid residues of GnRH decreases the 
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affinity of the peptide for the GnRH receptor (Coy et al., 1979). 
Substitutions of the first, second, and third amino acid residues by 
D-amino acids result in antagonists with good receptor binding 
activity and reduced biological activity (Conn et al., 1986) 
When substitutions are made that enhance the net hydrophobicity of the 
peptide, it enhances its biological potency. Replacement of the sixth 
amino acid residue with D-amino acids containing bulky, hydrophobic 
substituents yield agonist resistant to enzymatic cleavage (Coy et 
al., 1976). Substitution of the sixth amino acid with a D-amino 
combined with the Gly10 residue being changed for an ethylamide 
further enhances the affinity and potency of the GnRH agonists (Fujimo 
et al . , 1 9 7 4 ) • The available knowledge about how amino acid 
sustitutions affect the affinity and biological potency of GnRH, has 
facillitated the design of antagonists and agonists of GnRH. 
1 . 3 2+ Ca as a second messenger in LH secretion 
Three types of observations provide evidence that ca2+ acts as 
an intracellular messenger to stimulate LH release (1) GnRH-
stimulated LH release is inhibited by the removal of extracellular 
Ca 2+ and 2+ by Ca channel blockers; (2) elevation of the cytosolic 
ca
2
+ concentration is sufficient to stimulate LH release; and (3) 
GnRH causes measurable changes in ca2+ fluxes and in the cytosolic 
ca
2
+ concentration. 
1.3.1 The dependence of GnRH-stimulated LH release on extracellular 
Ca 2+ 
In 1968, Samli and Geshwind showed that the stimulation of LH 
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release from rat pituitaries by hypothalamic extract was dependent on 
extracellular ca2+. In the two decades since this finding, the role 
of ca2+ in the mechanism of GnRH-stimulated LH release has been 
extensively investigated, and the dependence of LH release on 
extracellular ca2+ has been repeatedly confirmed (Wakabayashi et al., 
1969; Hopkins and Walker, 1978; Marian and Conn, 1979; Bourne and 
Baldwin, 1980; Conn and Rogers, 1980; Borges et al., 1983; Bates 
and Conn, 1984; Jinnah and Conn, 1986; Conn et al., 1986; Hanson et 
al., 1987; Tasaka et al., 1988; Chang et al., 1988). 
1.3.2 Kinetic phases of LH release 
In kinetic studies, various investigators have demonstrated 
that GnRH-stimulated LH release occurs in a biphasic manner. Four 
reports describe a first phase of 40 - 60 minutes followed by a longer 
second phase of 3 - 4 hours (Bourne and Baldwin, 1980; Stern and 
Conn, 1981; Eddie et al., 1982; Borges et al., 1983). The protein 
synthesis inhibitor, cycloheximide, inhibited GnRH-stimulated LH 
release with its inhibitory effect seen only in the second phase of 
release (Bourne and Baldwin, 1980; Eddie et al., 1982). 
Bourne and Baldwin (1980) and Stern and Conn (1981) reported that the 
first phase was completely abolished by the removal of extracellular 
Ca2+ and that the second phase was only partially 2+ Ca -dependent. 
However, Borges et al. (1983), using dispersed cells and shorter 
collection periods, found that ca2+ was an essential requirement for 
both phases of release. These studies suggest that extracellular ca2+ 
is important in the first phase of release and for the maintenance of 
LH release. Other kinetic studies which investigated the first phase 
(0-60 minutes) of LH release more closely, have shown that this phase 
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of LH release is itself composed of two phases, a spike phase (0 - 5 
minutes) followed by a plateau phase (Hopkins and Walker, 1978; 
Hopkins and Gregory, 1981; Naor et al., 1982; Bates and Conn, 1984; 
Chang et al., 1986). 
The spike phase peaks within the first few minutes following the 
addition of GnRH. It occurs both when the cells are continuously 
exposed to GnRH (Hopkins and Walker, 1978; Naor et al., 1982; Borges 
et al., 1983) and when they are pulsed with GnRH (Chang et al., 1986). 
These authors presented conflicting data concerning the dependence of 
2+ the spike phase on extracellular Ca . The plateau phase was shown to 
2+ be abolished by the removal of extracellular Ca . Hopkins and Walker 
(1978) reported that the spike phase was unaffected by "ca2+-free" 
medium but markedly inhibited by EGTA. Naor et al. (1982) and Borges 
et al. (1983) reported that the spike phase was totally dependent on 
extracellular ca2+. This lack of consensus concerning the effect of 
the 
the 
2+ 
removal of extracellular Ca on the spike phase indicates that 
2+ Ca -dependence of this phase of LH release requires further 
investigation. 
1.3.1 The effects of ca2+ channel blockers on LH release 
Organic voltage-sensitive calcium channel (VSCC) blockers have 
2+ been used as tools to study the Ca entry routes which are activated 
by GnRH. It has been demonstrated that D600 (methoxyverapamil) 
inhibited GnRH-stimulated LH release (Hopkins and Walker, 1978; Conn 
and Rogers, 1980; Borges et al., 1983). In 1983, Conn et al. 
investigated the effects of a range of blockers of VSCC on LH release 
from rat gonadotropes. They reported that the phenylalkylamines (e.g. 
6 
verapamil and D600), were the most potent inhibitors of GnRH-
stimulated LH release, with diltiazem being less effective. In that 
study, the dihydropyridines (DHP) used did not inhibit LH release, and 
the authors concluded, since DHP are potent blockers of VSCC in 
muscle tissue, that there may be differences between the ca2+ ion 
channels in muscle tissue and those in gonadotropes. However, it has 
subsequently been demonstrated that DHP that are blockers of VSCC are 
able to inhibit LH release from both rat (Chang et al., 1984, 1986, 
1988; Tasaka et al., 1988) and chicken (Davidson et al., 1987, 1988) 
gonadotropes. 
Borges et al. (1983) reported that both the spike and plateau phases 
were partially inhibited by D600. In contrast, Bates and Conn (1984) 
reported that the spike phase was unaffected, with only the plateau 
phase being inhibited. Chang et al. (1986) concluded that the spike 
phase was inhibited by 40% in the presence of the DHP nitrendipine. 
Less specific inorganic ca2+ channel blockers have also been used to 
study ca2+ entry routes. Lanthanum (La3+) inhibited both GnRH- and 
K+-stimulated LH release (Hopkins and Walker, 1978). This 
that the VSCC that are activated by high K+ can be blocked 
suggests 
3+ by La . 
An analysis of the effects of various ca2+ channel blockers on the 
spike and plateau phases of LH release is presented in this thesis. 
1 . 4 Effects of the manipulation of the cytosolic calcium 
concentration on LH release 
1.4.1 Depolarization 
In order to further assess the role of ca2+ as a second 
messenger in LH release, it has been useful to manipulate the ca2+ 
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concentrations independently of GnRH. The treatment of cells with 
high concentrations 
investigators to 
+ 
of extracellular K has been shown by several 
stimulate LH release (Samli and Geshwind, 1968; 
Wakabayashi et al., 1969; Hopkins and Walker, 1978; Conn et al, 
1980; Davidson et al., 1987; Meier et al., 1988; Stojilkovic et al., 
1988). This secretagogue effect of high K+ suggests that in 
gonadotropes as in other cell types, membrane potential is maintained 
by K+ efflux through K+ channels. This secretagogue effect of high K+ 
suggests that in gonadotropes, as in other cell types, membrane 
potential is maintaned by + K efflux through K++ channels. High 
concentrations of K+ depolarise the plasma membrane, activating VSCC 
to allow ca2+ entry (Meier et al., 1988). The hormone-releasing 
action of K+ is inhibited by ca2+ removal and the organic blockers of 
VSCC, including DHP. 
Veratridine, a sodium channel agonist, depolarizes the cell membrane 
by allowing sodium (Na+) entry (Leabowitz et al., 1986; Sutro, 1986). 
This results in ca2+ entry via either VSCC or the Na+/ca2+ exchange, 
thereby stimulating LH release (Conn et al., 1980; Conn et al., 1983; 
Davidson et al., 1987). The ability of veratridine to stimulate LH 
release is inhibited by the specific Na+ channel antagonist 
tetrodotoxin and the ca2+ channel antagonist D600 (Conn et al., 1980; 
Conn et al., 1983). 2+ The removal of extracellular Ca also inhibits 
veratridine-stimulated LH release (Conn et al., 1980; 
al. , 1 987) . 
Davidson et 
Since both veratridine- and high K+-stimulated LH release are mediated 
via VSCC (Conn et al., 1980), these stimuli can be used to monitor the 
efficacy of VSCC blockers. 
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1.4.2 Ionophores 
Ionophores have the ability to transport ions across membranes 
independently of ion transport systems. ca2+ ionophores are able to 
transport ca2+ across the plasma membrane from an extracellular source 
2+ . 2+ 
and to release Ca from intracellular stores. The Ca ionophores 
A23187, X537A and ionomycin have been used to probe the mechanism of 
LH secretion. A23187 and ionomycin stimulated LH release from 
gonadotropes in a manner which was largely dependent on extracellular 
ca
2
+ (Hopkins and Walker, 1978; Conn et al., 1979; Kiesel and Catt, 
1984; Naor and Eli, 1985; Davidson et al., 1987). The ionophore 
X537A stimulated LH release independently of extracellular ca2+ (Conn 
et al., 1979). 
1.4.3 ca2+ channel agonists 
Although the DHP are commonly used as VSCC blockers, the DHP 
derivative Bay K8644 is a ca2+ channel agonist. Bay K8644 is thought 
to act by shifting the equilibrium between the open and closed states 
of the channels in favour of the open form, thereby increasing the 
mean channel opening time (Schramm et al., 1983; Towart and Schramm, 
1984). Bay K8644 alone stimulated LH release (Chang et al., 1986; 
Stojilkovic et al., 1988) and enhanced submaximal GnRH-stimulated LH 
release (Chang et al., 1986). Bay K8644 did not enhance LH release 
at high concentrations of GnRH. This suggests that the extent to 
which VSCCs are activated at the high concentrations of GnRH is 
sufficient to achieve maximal LH release. 
Maitotoxin (MTT), a dinoflagellate toxin, also stimulates LH release 
by allowing ca2+ entry via a ca2+ channel (Conn et al., 1987). MTT-
9 
stimulated LH 2+ release was inhibited by both Ca removal and 0600. 
MTT is thought to act by activating a ca2+ channel that is involved in 
GnRH-stimulated LH release. 
1 . 5 45ca2+ fluxes 
The availability of 45ca2+ has made it possible to study ca2+ 
fluxes across the plasma membrane. By means of 45ca2+ influx studies, 
3+ 45 2+ . in which La was used to displace surface bound Ca , Hopkins and 
Walker ( 978 ) t d th t d . . 45c 2+ 1 repor e a GnRH cause an increase in a influx 
during a 3-minute stimulation period. However, although LH release 
during this period was not inhibited by La3+, 45ca2 + influx was 
abolished. This suggested that the influx of ca2+ was not essential 
for the spike phase of GnRH-stimulated LH release. 
Two studies have reported that GnRH stimulates 45ca2 + efflux from 
cells preloaded with 45ca2+ (Williams, 1976; Hopkins and Walker, 
1978) . This stimulated efflux was maximal within the first 1-2 
minutes of stimulation and rapidly returned to basal levels. However, 
unlike 45ca2+ influx, this increase in 45ca2+ efflux was shown to be 
independent of extracellular ca2 +. Since secretion by GnRH was 
partially inhibited by the removal of extracellular ca2+ by EGTA 
(Hopkins and Walker, 1978) and 45ca2+ efflux was not inhibited, it 
45 2+ 
suggests that Ca efflux may be important for the residual portion 
2+ 
of the spike phase not inhibited by extracellular Ca removal. 
1 .6 Measurement of cytosolic ca2+ levels 
Since gonadotropes comprise only a small fraction of the cells in 
the anterior pituitary, the investigation of changes in the ca2+ 
10 
concentration in the cytosol of gonadotropes has required the 
development of methods for obtaining gonadotrope-enriched cell 
preparations. The use of fluorescent ca2+ chelators (quin-2 and fura-
2) which can be used 
measurement of changes 
as ca2+ indicators has facilitated the 
cells ' t l' C 2+ t t' ' in cy oso ic a concen ra ions in 
(Tsien et al., 1982; Grynkiewiz et al., 1985). 
Clapper and Conn (1985), using a gonadotrope-enriched cell population 
prepared by density elutriation and loaded with quin-2, showed that 
GnRH elevates the cytosolic ca2+ concentration. Similar results were 
obtained by Chang et al. (1986) and Limor et al. 
gonadotrope-enriched cell population prepared 
elutriation, also measuring changes in the 
(1987) using a 
by centrifugal 
cytosolic ca2+ 
concentration with quin-2. They showed that GnRH caused a rapid rise 
(6-8 seconds) in the cytosolic ca2+ concentration followed by a 
prolonged plateau phase of elevated ca2+ concentration which lasted 
for 15 minutes. The initial rise in ca2+ concentration was not 
affected by 2+ the removal of extracellular Ca whereas the plateau 
phase was decreased in the absence of ca2+. These workers suggested 
that the first phase of increased cytosolic ca2+ was due to the 
release of ca2+ from intracellular stores and that the influx of ca2+ 
across the plasma membrane sustains the elevated cytosolic ca2+ 
concentration during the plateau phase. 
They found that elevation of cytosolic ca2+ was dampened by prior 
stimulation with GnRH, a desensitization effect which is similar to 
the desensitization seen at the level of LH release. GnRH antagonist 
did not elevate ca2+ levels indicating that receptor occupation was 
not sufficient to elicit a ca2+ response, and that receptor activation 
1 1 
was also required. 
This rapid increase in the cytosolic ca2+ concentration due to GnRH 
coincides with the spike phase of GnRH-stimulated LH release. It was 
therefore concluded that this release of ca2+ from intracellular 
stores is important to the spike phase of LH release. 
1.7 Calmodulin (CAM) 
A potential role for CAM in GnRH-stimulated LH release was 
suggested by the finding that GnRH caused the redistribution of CAM 
from the cytoplasm to the plasma membrane where it associated with 
GnRH receptor patches (Conn et al., 1981; Jennes et al., 1985; Naor 
et al., 1985). Studies using CAM antagonists have also suggested a 
possible role for CAM in LH release. Conn et al. (1981) reported that 
the CAM antagonist pimozide inhibited GnRH-stimulated LH release. 
Stimulation of LH release due to other secretagogues that elevate the 
cytosolic ca2+ concentration is also inhibited by CAM antagonists. 
Davidson et al. 
chlorpromazine 
(1987) reported that trifluoperazine, W7, 
inhibited A23187- and veratridine-stimulated 
release. These results suggest that the CAM antagonists act at a 
distal to the mobilization of Ca 2+ and possibly at the level 
activation of CAM. 
However, the interpretation of studies using CAM antagonists is 
and 
LH 
site 
of 
not 
straightforward, since these drugs can inhibit protein kinase C (Mori 
et al., 1981). In addition, recent studies suggest that the 
inhibition of ca2+-triggered exocytosis by CAM antagonists can be 
explained by an effect on membrane surface charge density, due to an 
association of these lipophilic cations with the membrane (Whitaker, 
12 
1987). Thus the observed inhibition of secretion by these drugs may 
not be due to CAM inhibition, and the role of CAM in LH release 
remains unclear. 
1.8 Inositol Phosphate Metabolism 
As early as 1953, Hokin and Hokin demonstrated a possible role 
for phosphatidylinositol (PI) turnover in signal transduction. 
Subsequently, it was proposed that the increase in PI turnover could 
be linked to the mechanism of action of C 2+ b'l' ' a -mo 1 1z1ng hormones 
(Mitchell et al., 1976). Since then, the metabolism of inositol 
phospholipids and their relation to ca2+ mobilization have been 
extensively investigated, and recently reviewed (Sekor and Hokin, 
1986; Berridge, 1987; Majerus et al., 1988). In brief, receptor 
activation of phospholipase C (PLC) leads to the hydrolysis of 
phosphatidylinositol-4,5-bisphosphate (PIP2) to 1,2 diacylglycerol 
(DAG) and inositol-1,4,5-triphosphate (IP3). Both of these compounds 
act as second messengers, IP3 causing intracelluar ca2+ mobilization 
(Berridge 1984, 1987) and DAG activating protein kinase C (Nishizuka 
1984, 1986). 
Recently it has been shown that GnRH induces rapid phosphodiester 
hydrolysis of phosphoinositides in pituitary gonadotropes (Kiesel and 
Catt, 1984; Andrews and Conn, 1986; Naor et al., 1986). Kiesel and 
Catt (1984), using an enriched population of gonadotropes, 
demonstrated that GnRH stimulated the incorporation of 32P into total 
phospholipids, phosphatidylinositol (PI) and phosphatidic acid (PA). 
PA stimulated both LH release and cyclic guanosine 3' ,5'-monophosphate 
formation in a calcium-dependent manner. This suggested that the PA 
formed in response to GnRH receptor activation might have an important 
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function in the mechanism of LH release. 
Similarly, Andrews and Conn (1986), also looking at short-term 32P 
labelling, showed that GnRH rapidly stimulated 32P incorporation into 
PA, PI, PIP and PIP2. Data obtained from short-term 32P labelling 
reflect changes in the turnover of phospholipids rather than mass 
changes. Mass changes in phospholipids were investigated in cells 
labelled to isotopic equilibrium with 32P (Andrews and Conn, 1986). 
In these experiments GnRH stimulated a rapid loss of labelled PI, PIP 
and PIP2. These data suggest that GnRH activates PLC leading to 
changes in the turnover rates of these metabolites. Morgan et al. 
(1987) showed that PIP and PIP2 are the principal targets of the PLC 
activated by GnRH rather than PI. 
In gonadotropes pre-labelled with 3H-myo-inositol, GnRH stimulated the 
rapid formation of IP3, IP2 and IP1 (Morgan et al., 1986; Naor et 
al., 1986). The effect on IP3 was biphasic and the rapid increase in 
IP3 was followed by a nadir and a second rise between 5 and 20 minutes 
(Naor et al., 1986). The initial rapid increase in IP3 corresponds to 
a rapid loss of PI and PIP2 when gonadotropes are stimulated with 
GnRH. The increases in IP2 and IP1 occurred with a slower time-course 
than that of IP3, increased levels of these products being observed 90 
minutes after stimulation (Huckle and Conn, 1987). The stimulatory 
effect of GnRH on IP3, IP2 and IP accumulation is abolished in the 
presence of GnRH antagonist (Naor et al., 1986), indicating that the 
increase in inositol phosphate production is a receptor-mediated 
event. 
Using HPLC to resolve isomers of the inositol phosphates, Morgan et 
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al. (1987) showed that more than one isomer of IP3 was produced by 
the gonadotropes. These workers showed that GnRH stimulated the 
production of I(1,4,5)P3 rather than the I(1,3,4)P3 isomer. This was 
followed by progressive increases in I(1,4)P2. GnRH also stimulated 
the elevation of IP4, IP5 and IP6; however, the roles of these 
metabolites are not known. 
In contrast to LH release, Huckle and Conn (1987) reported that IP 
production was not inhibited in ca2+-free medium. In addition, the 
ca
2+ channel blocker D600, at concentrations which inhibited GnRH-
stimulated LH release, did not inhibit IP production. At high 
concentrations, D600 inhibited both IP production and LH release. 
Pimozide, a CaM antagonist, inhibited GnRH-stimulated LH release but 
not IP production. From these results the authors concluded that 
GnRH-stimulated IP production was independent of extracellular ca2+ 
2+ and the Ca -CaM system. 
1.9 Protein Kinase C 
A second messenger role for DAG, a product of the hydrolysis of 
phospholipids, was first recognized by Nishizuka (1984). He observed 
that DAG increased the affinity of protein kinase C for ca2+ and 
phosphatidylserine (PS), thereby causing activation of the enzyme at 
resting intracellular ca2+ concentrations. DAG interacts with protein 
kinase C at the same site as phorbol esters which are potent 
activators of the enzyme (Sharkey et al, 1984). Phorbol esters are 
not only more potent than DAG in activating protein kinase C, but they 
have a prolonged action since they are not readily metabolized. GnRH 
has been shown to stimulate an immediate and transient (5 minute) 
1 5 
increase in DAG in cells labelled to isotopic equilibrium with 3H-
arachidonic acid (Andrews and Conn, 1986). 
Phorbol esters have been shown to stimulate LH release in several 
studies (Smith and Vale, 1980; Naor and Catt, 1981; Smith and Vale, 
1981; Conn et al., 1985; Naor et al., 1985; Davidson et al., 1987). 
Phorbol ester-stimulated LH release is ca2+-independent and not 
inhibited by ca2+ removal and ca2+ channel antagonists. More 
recently, the synthetic DAG, Sn-1-oleoyl-2-acetylglycerol (OAG) and 
Sn-1,2-dioctanocylglycerol (diC5) have been reported to stimulate LH 
release (Conn et al., 1985). The 3' hydroxyl group of 
diacylglycerols was found to be important for LH release. 
these 
In the unstimulated pituitary, 70% of the protein kinase C activity is 
in a soluble, cytosolic form and 30% is found in the particulate 
fraction, i.e. bound to the membranes (Naor et al., 1985). In in 
vitro studies using ovariectomized rats, GnRH was reported to 
stimulate the redistribution of protein kinase C from the soluble to 
the particulate fraction (Naor et al., 1985; McArdle et al., 1986). 
GnRH-stimulated redistribution of protein kinase C was inhibited by 
D600 at concentrations that inhibit LH release (McArdle and Conn, 
1986), suggesting that protein kinase C redistribution occurs as a 
result of entry 2+ of extracellular Ca . 
The phorbol ester, 12-0-tetradecanoyl phorbol acetate, interacts 
synergistically with the ca2+ ionophore A23187 to stimulate LH release 
(Harris et al., 1985; Naor et al., 1985; Davidson et al., 1987). 
Synergism has also been observed between phorbol esters and stimuli 
which elevate ca2+ by activating VSCC (high K+ and veratridine) 
(Davidson et al., 1987). This synergistic interaction was inhibited 
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by extracellular Ca2+ removal, D600, and CaM antagonists 
trifluoperazine and chlorpromazine (Davidson et al., 1987). This was 
interpreted as suggesting that the synergistic interaction was due to 
an event that occurs distal to the activation of CaM However, other 
interpretations are possible in light of the action of these drugs on 
ca
2
+ binding to membranes (Whitaker et al., 1983) as discussed above 
in section 1.5. 
Pretreatment of pituitary cells with phorbol esters decreases protein 
kinase C activity and inhibits the response of the gonadotropes to 
subsequent challenges with protein kinase C activators (Huckle and 
Conn, 1987; McArdle et al., 1987). However, this depletion of 
protein kinase C activity had no effect on GnRH-stimulated LH release, 
and the authors concluded that protein kinase C may not be involved in 
GnRH-stimulated LH release (McArdle et al., 1987). In contrast to 
this, retinal, a putative inhibitor of protein kinase C, at a dose 
which inhibited TPA stimulation of LH release, reduced the LH release 
due to GnRH by 40%. The spike phase of release was unaffected with 
only the plateau phase being partially inhibited, leading the authors 
to conclude that protein kinase C-dependent mechanisms participated in 
the maintenance of the LH response. 
Although numerous compounds have been shown to be protein kinase C 
inhibitors in vitro, they all either (1) show toxic effects on whole 
cells and/or (2) lack specificity in that they affect other cellular 
processes. The absence of a specific and non-toxic inhibitor of 
protein kinase C makes it difficult to determine to what extent GnRH 
stimulation of LH release is dependent on the activation of protein 
kinase C. 
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Pre-treatment with the protein kinase C activator TPA inhibited GnRH-
stimulated IP production but not LH release (McArdle et al., 1987). 
This effect is analagous to the inhibitory effect of protein kinase C 
activators on agonist-induced IP production in other cell types 
(Ballester and Rosen, 1985; Melloni et al., 1988). This is a 
possible mechanism by which protein kinase C activators could uncouple 
the GnRH receptor from IP production. 
In summary, a role for protein kinase C in GnRH-stimulated LH release 
is suggested by the fact that (1) protein kinase C activators 
stimulate LH secretion; (2) GnRH stimulates inositol lipid hydrolysis; 
and (3) protein kinase C translocates to the membrane on GnRH 
stimulation. 
1.10 Cyclic AMP (cAMP) as a second messenger in LH release 
The role of cAMP as a mediator of LH release is controversial. 
In early studies it was reported that GnRH was able to stimulate LH 
release and increase cellular cAMP concentrations (Borgeat et al., 
1972; Makino, 1973; Naor et al., 1975; Bonney and Cunningham, 1977; 
Sen and Menon, 1977; Bourne and Baldwin, 1987). Other studies were 
unable to demonstrate that GnRH increased cellular cAMP concentrations 
(Sundberg et al., 1976). Conflicting data have made it difficult to 
assess the role of cAMP as a second messenger in the mechanism by 
which GnRH stimulates LH release. 
Cholera enterotoxin stimulated an increase in the concentration of 
cellular cAMP without stimulating LH release (Naor et al., 1975; Sen 
and Menon, 1979). These studies had shown that GnRH increased 
cellular cAMP concentrations. These authors concluded that cAMP did 
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not play a role in GnRH-stimulated LH release since an increase in 
cAMP did not necessarily coincide with the release of LH. Naor et al. 
(1975) reported that the cAMP phosphodiesterase inhibitors 1-methyl-3-
isobutyl-xanthine (IBMX) and theophylline raised cellular cAMP levels 
but did not stimulate LH release. Sundberg et al. (1976) were also 
unable to show any effect with theophylline and cholera enterotoxin on 
LH release. However, in other studies theophylline (Makino, 1975; 
Bonney and Cunningham, 1977) and IBMX (Wun et al., 1988) have been 
reported to stimulate LH release. 
Membrane-permeant cyclic AMP analogues have also been used to 
investigate the role of cAMP in LH release. Dibutyryl cAMP (dBu-cAMP) 
has been shown to stimulate LH release (Makino, 1973; Bonney and 
Cunningham, 1977; Kerchet et al., 1977). Similarly, 8-Br-cAMP has 
also been shown to stimulate LH release (Wun et al., 1988). This was 
confirmed by Smith et al. (1982), who showed that these cAMP analogues 
stimulated LH release but inhibited the binding of GnRH to its 
receptor. 
In contrast to these data, Liu et al. (1981) and Turgeon 
(1986) reported that 8-Br-cAMP and dBu-cAMP did not 
and Waring 
stimulate LH 
release on their own but did potentiate GnRH-stimulated LH release. 
Thus, conflicting data about the effects of these cAMP analogues make 
it difficult to assess the role of cAMP in LH release. 
More recently, forskolin, an activator of adenylate cyclase (Seamon et 
al., 1981), has been used as a tool to investigate the role of cAMP in 
GnRH-stimulated LH release. Forskolin increased cellular cAMP 
concentrations (Cronin et al., 1984), stimulated LH release on its 
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own, and enhanced GnRH-stimulated LH release (Cronin et al., 1983 and 
1984; Evans et al., 1986). Turgeon and Waring (1986) demonstrated 
that forskolin enhanced GnRH-stimulated LH release but had no effect 
on its own. Recently, Bourne and Baldwin (1987) demonstrated that 
sodium flufenamate, an inhibitor of cAMP production, inhibited both 
the release of LH by GnRH and its ability to increase the cellular 
cAMP concentration. This suggested that cAMP may have a direct role 
in the mechanism by which GnRH stimulates LH release. 
In conclusion, the available evidence suggests that cAMP may play a 
role in GnRH-stimulated LH release. However, the relationships and 
interactions between cAMP and other second messengers (ca2+ and 
diacylglycerol) in GnRH action require clarification. 
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2. METHODS 
2.1 Preparation of primary cultures of chicken anterior pituitary 
cells 
Anterior pituitaries were removed within 2 hours of death, from 
chicken heads (Golden Grove Poultry Company, Cape Town, South Africa) 
that had been kept on ice and washed with disinfectant (Hibitane: 0.5% 
chlorhexidine gluconate in 80% methanol). The pituitaries were 
collected into Dulbecco's Modified Eagles Medium (DMEM) (Gibco, Grand 
Island, NY) buffered with 20 mM HEPES (pH 7.4) at room temperature. 
The pituitaries were then washed twice in buffer A which comprised 
(millimolar): NaCl, 140; KCl, 4; MgCl2, 1; Na2HP04, 1.4; 
8.3; HEPES, 20 (pH 7.4); and phenol red, 6 mg/liter. 
glucose, 
The pituitaries were minced with a razor blade, and digested with 
collagenase for 1 hour at 37°C with continuous agitation by a slowly 
rotating stirrer. The collagenase solution consisted of collagenase 
0.9% (wt/vol) (155 U/mg, Worthington Biochemical Corporation Freehold, 
NJ) and 1.8 mg/liter deoxyribonuclease (Miles Laboratories, Elkhardt) 
in a buffer of (millimolar) NaCl, 137; KCl, 5; Na2HP04, 0.7; HEPES, 
25 (pH 7.2); Ca2Cl2, 0.36; glucose, 10 and 1% (wt/vol) bovine 
albumin (BSA) (fatty acid free, Pentex fraction v, Miles 
Laboratories). The suspension was passed up and down a 5 ml pipette 
at 
for 
20 minute intervals during the incubation and finally 
5 minutes at 500 x g. The pellet was resuspended in 
centrifuged 
2+ Mg -free 
buffer A containing 0.5 mM EDTA and 0.3% (wt/vol) BSA at room 
temperature, and recentrifuged. This step was repeated, and the 
pellet resuspended in DMEM. The cell suspension was filtered through 
nylon gauze and diluted into DMEM with 10% fetal calf serum (FCS) 
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(Gibco), penicillin (60 mg/liter), streptomycin (100 mg/liter), and 
amphotericin B (20 mg/liter). The suspension was dispensed into 
plastic tissue culture wells (Falcon) at a density of 1.5 or 3 
pituitary equivalents per well (6-well plates) or 0.7 pituitary 
equivalents per well (24-well plates). One pituitary equivalent 
represents 5 - 6.7 x 10 5 cells as determined by coulter counter. The 
cells were cultured at 37°C in 8% CO2 for 24 hours, after which the 
medium was replaced with fresh medium without amphotericin B. The 
cells were used for experiments after a further 24 hours in culture. 
2.2 Cell stimulation 
The cells were washed once briefly, followed by two five-minute 
washes with buffer A containing 1 mM CaCl2 and 2% FCS. The cells were 
washed with 2ml of washing buffer and placed on a rotary shaker (60 
rpm) at 37°C during the wash periods. The cells were stimulated at 
37°C in the same buffer cotaining the test secretagogue, except where 
indicated. At the end of the stimulation period, the medium was 
collected, and centrifuged at 4°C for 5 minutes at 500 x g to remove 
cells that had detached during the stimulation period. The 
supernatants were stored at -20°C prior to radioimmunoassay (RIA) for 
chicken LH. For the measurement of total cellular LH, cells were lysed 
with 0.5 ml 1% nonidet-P40. cAMP was extracted from the cells using 
0.1 M HCl which was subsequently neutralised with 0.1 M NaOH, and 
stored at -20°C prior to assay for cAMP using a RPA 509 cAMP assay kit 
(Amersham, England). 
Where detailed time-course studies were performed, the total volume of 
medium was collected at the end of each time point and replaced with 
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fresh medium. In experiments where LH release was divided into spike, 
intermediate and plateau phases, the total volume of medium was 
collected and replaced at 3, 9 and 30 minutes after the start of 
stimulation. In studies in which gadolinium 
phosphate was omitted from the stimulation 
precipitation. 
2.3 45ca2+ efflux 
buffer 
was 
to 
used, 
avoid 
Pituitary cells which had been cultured for 48 hours in 6-well 
tissue culture plates (3 pituitary equivalents per well) were pre-
incubated for 1.5 hours with 45ca2+ (10 µCi/ml) in 0.5 ml buffer A 
containing 2+ 0.2 mM unlabelled Ca and 5% FCS at 37°C. The labelled 
cells were then washed 6 times with 1ml buffer A containing 1 mM 
CaCl2. The cells were placed on a rotary shaker (60 rpm at 37°C) for 
5 minutes during each of the last three washes. This extensive 
washing procedure 45 2+ allows exchange of Ca bound to extracellular 
sites and located in rapidly exchanging intracellular compartments. 
The basal fractional efflux rate of the remaining 45ca2+ was 2-3%/min 
(see results section 3.5). This corresponds to a kinetic compartment 
with an average half life of 35-70 minutes. 45ca2+ efflux was 
measured by replacing the efflux buffer at 3 minute intervals. The 
composition of the efflux buffer was varied as indicated. At the end 
of the efflux period the cells were solubilized in 0.5% sodium dodecyl 
Sulphate t d t . th . . 11 1 45ca2+. Rd' t· 't o e ermine e remaining ce u ar a ioac ivi y 
was determined by scintillation counting. 45ca2+ fractional efflux 
was 45 2+ calculated as Ca released during each 3-minute interval as a 
percentage of the calculated total cellular 45ca2+ at the start of the 
3-minute interval. 
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2.4 Inositol phosphate production 
Pituitary cells in 6-well tissue culture plates (3 pituitary 
equivalents per well) were prelabelled for 20 hours in 2 ml/well of 
Medium 199 (Gibco, Grand Island, NY) containing 5 µCi/ml of 3 H-myo-
inositol (Amersham). Cells were washed for two five-minute periods 
and then pre-incubated for 10 minutes in buffer A containing 1 mM 
C 2+ a ' 2% FCS, and 10 mM LiCl, before incubation with GnRH in the same 
buffer. At the end of the stimulation period, the medium was removed 
and replaced with boiling water, after which the plates were left for 
10 minutes on a slowly rotating shaker, at room temperature. 
Supernatants containing the water-soluble inositol phosphates were 
stored at -20°C prior to being chromatographed on dowex anion exchange 
columns (Martin, 1986). 
The columns were made using Gilson P5000 pipette tips plugged with 
glass wool, containing 0.5 ml bed of anion exchange resin (Dowex-1, 
1x8-200, Sigma). The dowex was originally in the chloride form and 
was equilibrated with 3M ammonium formate (AF) for 1 hour to convert 
the resin to the formate form. The dowex was washed with 3M AF prior 
to the addition of the samples to the column. After the samples had 
been added, the columns were washed with 10 ml water to elute the 
excess 
3H-myo-inositol that had not been incorporated into the 
inositol phosphates. Glycerophosphorylinositol was eluted with 2 x 3 
ml of 25 mM sodium tetraborate/60 mM sodium formate. IP1, IP2 and IP3 
were eluted with 2 x 3 ml of 0.2 M AF, 0.6 M AF and 1 M AF in 0.1 
formic acid. It was confirmed that the putative IP1 fraction coeluted 
with authentic myo-[2- 3H] inositol 1-phosphate (The Radiochemical 
Centre, Amersham) and that 3H-inositol was completely eluted by the 
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washing procedure used. Radioactivity recovered was determined by 
scintillation counting in a Beckman LS3801 scintillation counter using 
the scintillant Packard Insta-gel (Illinois, USA). 
3.5 Radioirnrnunoassay of LH 
RIA of chicken LH was performed as previously described (Follett 
et al., 1972). All samples from an experiment were assayed in 
duplicate in a single assay. Intrassay and interassay coefficients of 
variation were 7% and 16%, respectively. The inorganic ions used in 
the stimulation experiment did not interfere with the RIA (see Table 
2+ below). A control value in the RIA was assayed in the presence of Co 
3+ 
and Gd (see Table below). 
EFFECT OF Co2+ AND Gd3+ ON THE RIA 
SAMPLE % CONTROL 
Control 2+ Control+ co2+ Control+ co3 Control+ Gd+ 
Control+ Gd 3+ 
0.3 mM 
1 mM 
0.3 mM 
1 mM 
100 
104 
98 
106 
105 
2.6 Reagents 
[Gln8 ]GnRH was synthesized by R.C.del.Milton,Department of 
D600 Chemical Pathology, University of Cape Town. 
(methoxyverapamil)(Knoll AG, Ludwigshafen, FRG) was dissolved in 
dimethylsulphoxide, and nifedipine (Bayer Pharmaceuticals, 
Johannesburg, South Africa) in ethanol. Nifedipine is light-sensitive 
and was handled accordingly. TPA and forskolin were bought from Sigma 
Chemical Co. (St. Louis, MO), and were dissolved in ethanol. IBMX was 
25 
obtained from the same source, but was dissolved in 
dimethylsulphoxide. Final solvent concentrations were 0.1% (vol/vol) 
or less and did not affect LH release. 0-Conotoxin was synthesized by 
J.E. Rivier, The Salk Institute (La Jolla, CA). Gadolinium chloride 
was purchased from ICN Biochemicals (CA). Ruthenium red was purchased 
from Sigma Chemical CO. (St.Louis, MO), and was assumed to be 35% pure 
. 45 2+ 3 
,as stated by the supplier. Ca and myo-[2- H]inositol were from Du 
Pont de Nemours International (Zurich, Switzerland). 125I was obtained 
from Amersham, England. 
2.7 Data presentation 
Each figure shows results obtained from a single experiment which 
was representative of two to six experiments. Points represent the 
mean± SEM of triplicate wells. Where indicated, some figures contain 
data which were combined from more than one experiment. 
26 
RESULTS 
Part 1: INVESTIGATION OF THE Ca2+ DEPENDENCE OF GnRH-STIMULATED LH 
RELEASE. 
3.1 Kinetics of GnRH-stimulated LH release 
GnRH stimulated LH release from primary cultures of chicken 
pituitary cells in a biphasic manner (Fig.1). GnRH consistently 
induced a rapid initial spike of LH release within the first 2 minutes 
of stimulation. This spike phase was followed by a sustained plateau 
phase of LH release. This biphasic LH response to stimulation with 
GnRH was closely similar in 5 detailed time-course experiments of the 
type shown in Fig.1. The 3 intervals chosen for further study were 
the spike phase (0-3 min), intermediate phase (3-9 min) and the 
plateau phase (9-30 min). Table 1 shows the results from 20 
experiments in which LH release in these 3 intervals was measured. In 
subsequent data presented, results for the spike and plateau phases 
only are shown for clarity, since the intermediate phase was shown to 
possess characteristics intermediate between these two phases. 
The EC50 for GnRH stimulation of the spike and plateau phases of LH 
release were similar being 2x10- 9 Mand 8x1o- 10 M respectively (Fig.2). 
3.1 .1 Dependence of GnRH-stimulated LH release on protein synthesis 
To determine whether or not the LH released during the spike 
and plateau phases was dependent on protein synthesis, the kinetics of 
GnRH-stimulated LH release was investigated in the absence and 
presence of cycloheximide. Cycloheximide at a concentration of 20 
µg/ml inhibited the incorporation of 3H-phenylalanine by 95.8% (Table 
2) (i.e. inhibited protein synthesis effectively), but had no effect 
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Kinetics of GnRH-stimulated LH release in cultured chicken 
pituitary cells. 
( e) Basal, -6 10 M GnRH present continuously from t = 
0 minutes. The medium was changed at 1 min intervals. This 
experiment is representative of 5 similar experiments. 
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Table 1 
------
EX NO 
------
108 
109 
11 0 
111 
11 3 
11 4 
1 1 6 
117 
118 
119 
1 21 
122 
123 
127 
128 
131 
133 
135 
138 
1 41 
MEAN 
± SEM 
The three phases of GnRH-stimulated LH release (results from 
20 independent experiments). 
-------------------------------------------------------
LH RELEASED ng/pituitary equivalent 
-------------------------------------------------------
SPIKE PHASE INTERMEDIATE PHASE PLATEAU PHASE 
BASAL GnRH BASAL GnRH BASAL GnRH 
---------------- ---------------------- ---------------
0.48 9.02 0.62 5.82 1. 63 8.00 
1 . 88 18.00 0.48 14.54 2.20 21 . 53 
1 . 71 21 . 43 4.01 31. 24 3.70 17.31 
1 . 51 17.48 0.85 5.46 1 . 7 3 9. 18 
1 . 1 2 11 . 22 1 . 18 9.38 3.83 12.63 
5.38 21. 57 2.91 10.63 2. 13 15.33 
3.93 47.43 1 . 1 7 11 . 1 3 7.60 32.23 
2.67 23.14 0.88 7. 41 1. 90 1 0. 17 
1 . 32 65.53 1 . 69 31. 30 6.33 36.58 
1 . 05 27.68 1 . 08 14.65 2.36 24. 19 
1 . 93 49.06 2. 16 19.07 5.94 34.77 
1 . 77 20. 18 1. 69 23.28 4.99 37.92 
1 . 27 22.62 1. 46 20.41 4.53 29.00 
0. 16 24.25 0.83 26.88 1 . 56 40.57 
1 . 02 27.70 1. 00 21. 25 4.99 35.05 
0.45 1 0. 51 0. 31 7. 10 3.20 13.55 
0.35 29.63 0.53 14.47 3.33 31. 25 
0.80 12.52 1. 46 8.94 2.21 25.33 
1. 44 20.24 0.03 16.74 2.44 34.72 
1. 40 40.08 3. 13 15.58 4.59 21 . 77 
----- ----- -----
1 . 59 25.96 1 . 37 14.89 3.56 24.56 
±0.28 ± 3.23 ±0.23 ± 1. 60 ±0.39 ± 2.38 
Cells were stimulated with a maximal concentration of GnRH or 
10-6 M) at time t = 0. Three phases of GnRH-stimulated LH release were 
identified from kinetic experiments: the spike phase (0-3 min), 
intermediate phase (3-9 min) and the plateau phase (9-30 min). The 
medium was replaced with fresh medium at the start of each period. At 
the end of each period (3, 9 and 30 minutes) the medium was collected 
for LH determination. 
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Fig.2 GnRH dose response curves for the spike (0-3 min) and plateau 
(9-30 min) phases of LH release. This experiment is 
representative of 3 similar experiments. 
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Table 2: Inhibition of 3H-Phenylalanine incorporation 
TCA-insoluble material by cycloheximide over a 
into 
60-min 
period. The data were obtained from triplicate wells 
of the same batch of cells as used in the experiment shown 
in Fig. 3 . The data represented are data obtained in a 
single experiment. This data is similar to data obtained in 
two similar experiments. 
CPM ( 3H-Phe) Mean ± SEM % 
No 14607 14049 
cycloheximide 14949 ± 100 
12592 735 
805 626 
20 µg/ml 476 ± 4.15 
cycloheximide 498 92 
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on GnRH-stimulated LH release for up to 1 hour (Fig.3). During this 1 
hour period, GnRH does not deplete the cell of LH, since the amount of 
LH released by the ca2+ ionophore A23187 plus the phorbol ester TPA 
is much greater than that released by GnRH (Fig.3). GnRH typically 
released 3.0~ 0.37% (n=3 experiments) of the total immunoreactive 
cellular LH during a 20-minute stimulation period. The large amount of 
LH release induced by A23187 plus TPA was also not significantly 
inhibited by cycloheximide (Fig.3). 
3.2 The effect of extracellular ca2+ removal and intracellular ca2+ 
depletion on GnRH-stimulated LH release. 
In nominally ca2+-free medium, without a ca2+ chelator, both 
the spike and plateau phases of GnRH-stimulated LH release were 
inhibited (Figs.4 & 5). LH release in the absence of extracellular 
C 2+ d ' th 'k d 1 t h 39 0 3 8 ( 3) d a ur1ng e sp1 e an pa eau pases was . ± • n= an 4.8 
± 2.9 (n=3) percent respectively of release in media containing 1 mM 
CaCl2 (Fig.4). Thus both phases of release are dependent on 
extracellular ca2+, with the spike phase being partially inhibited by 
ca
2+ removal and the plateau phase being totally abolished. The 
degree of inhibition of the spike phase was dependent on the pre-
incubation period in ca2+-free medium prior to stimulation with GnRH 
(Fig.6). Unlike the plateau phase, the spike phase was never totally 
abolished even after 10 minute pre-incubation in the absence of 
extracellular ca2+. Similarly, in the presence of the ca2+-specific 
chelator EGTA, a portion of the spike phase persisted, while the 
plateau phase was abolished (Fig.4). 
To determine whether or not this extracellular ca2+ independent 
portion of the spike phase was dependent on the mobilization of stored 
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Dependence of GnRH-stimulated LH release on protein 
synthesis. 
Top: Cells stimulated with GnRH (10-G M) Bottom: Cells 
stimulated with A23187 (1 µM) and TPA (50 nM). These 
secretagogues were present continuously from t = 0 minutes. 
Cycloheximide (20 µg/ml) was present continuously from t = 
-10 minutes. This experiment is representative of 3 similar 
experiments. 
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Effect of extracellular ca2+ removal and intracellular ca2+ 
depletion on the spike (0-3 min) and plateau (9-30 min) phases 
of GnRH-stimulated LH release. 
The cells were pre-incubated with 1 mM ca2+, ca2+_free medium 
(no chelator), 0.1 mM EGTA, or 0.5 mM EGTA plus 1 µM A23187 
for 10 minutes prior to stimulation with GnRH. Data from 2 to 
4 experiments has been normalized to percent of control (1 mM 
ca2+). 
Basal release (in the presence of 1mM ca2+) was subtracted and 
negative values reflect LH release below basal. 
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intracellular ca2+, the cells were pretreated in medium containing 
EGTA and the ca2+ ionophore A23187. This treatment was designed to 
deplete 2+ intracellular stores of Ca . The spike phase was completely 
abolished in cells pre-incubated in medium containing 0.5 mM EGTA and 
2+ 1 uM A23187 for 10 minutes prior to stimulation with GnRH in Ca -free 
medium plus 0.5 mM EGTA (Fig.4). This indicates that the portion of 
the spike phase which is independent of extracellular ca2+ is 
dependent on the mobilization of stored intracellular ca2+ which can 
be depleted by this pre-treatment. In contrast the plateau phase of 
release is entirely dependent on extacellular ca2+, since this phase 
of release is abolished in ca2+-free medium. 
3.2.1 2+ The effect of the removal of extracellular Ca on basal 
LH release 
It was noted that in experiments in which the cells were 
exposed 2+ to Ca -free medium, the basal LH release levels were raised 
(Table 3). This increase in basal LH release was enhanced even 
further in the presence of the ca2+ chelator EGTA (Table 3). The 
mechanism by which this increase in basal release occurs is unclear. 
3.3 The effect of organic voltage-sensitive calcium channel (VSCC) 
blockers on GnRH-stimulated LH release 
Since both the spike and plateau phases of LH release were 
2+ 2+ dependent on extracelllular Ca , the routes of Ca entry (e.g. VSCC) 
in these two phases of release were investigated using various ca2+ 
channel blockers. 
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Table 3: The effect of extracellular ca2+ removal on basal LH 
release 
Ca2+ (DIM) 
1 
0 
0 
EGTA 
(DIM) 
0 
0 
0. 1 
LH release 
(ng/pit. equiv./20 min 
2.7 ± 0.4 
7.0±1.1 
13.3 ± 1.4 
(Mean± SEM) 
n 
6 
3 
3 
The cells were pre-incubated for 10 minutes in the indicated medium, 
then basal LH release during the subsequent 20 minutes was determined. 
Results are mean± SEM of n independent experiments. 
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3.3.1 Inhibition of GnRH-stimulated LH release by D600 
The effect of methoxyverapamil (D600), a specific VSCC blocker, 
was both qualitatively and quantitatively different from the effects 
of ca2+ removal on GnRH-stimulated LH release. Unlike the removal of 
extracellular C 2+ a ' D600 caused only a minor inhibition of the spike 
phase (Fig. 7 & 8). A time course examining the kinetics of GnRH-
stimulated LH released by D600 was done once using 2 min time 
intervals an was repeated with 3 min and 5 min intervals. 
The efficacy of D600 in blocking VSCC was monitored by its ability to 
inhibit K+-stimulated LH release. K+ (50 mM) depolarizes the cell 
membrane, opening VSCC, 2+ to allow Ca entry which results in LH 
release (Meier et al., 1988). Similar to GnRH, K+ elicited a rapid 
spike phase of LH release followed by a sustained plateau phase of LH 
release (Fig.7). In 4 experiments D600 inhibited the spike and 
plateau phases of K+-stimulated LH release by 81.0 ± 3.8% and 93.2 ± 
3.3% (Table 4) respectively. These control experiments indicate that 
the dose and pre-incubation period of D600 used was adequate to block 
VSCC's. 
To determine if increasing the extracellular ca2+ concentration would 
be able to overcome the inhibition of LH release by D600, an 
experiment was done at two ca2+ concentrations. The degree of 
inhibition of the spike and plateau phases of GnRH-stimulated LH 
release by D600 was similar at both 1 mM and 5 mM ca2+ (Table 5) . 
Dose response curves for the effects of D600 were determined. The 
plateau phase of GnRH-stimulated LH release was inhibited by D600 with 
IC50 = 0.2 µM (Fig.8). The plateau phase of K+-stimulated LH release 
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Dose-inhibition curves of the effect of D600 on spike (0-3 
minutes) and plateau (9-30 minutes) phases of GnRH- and K+-
stimulated LH release. 
D600 was present 10 minutes before the start of stimulation. 
ce,O) Basal, <•,D> 10 -G GnRH, (•,O> 50 mM K+. 
2+ Extracellular Ca was 1 mM. This experiment is representative 
of 3 similar experiments. 
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Table 4: Percentage inhibition of GnRH and K+-stimulated LH 
2+ 
release by the Ca channel blocker D600 (20 µM) 
--------
-------------------- ---------------------
EXPT SPIKE PLATEAU SPIKE PLATEAU 
NO. 0-3 min 9-30 min 0-3 min 9-30 min 
--------
--------- ---------- --------- -----------
76 5. 1 54.3 78.8 84.6 
79 11 58 
83 21 76 
84 23.1 51 . 1 81. 2 99.6 
94 8 62 73 97 
91 13 50 
100 7 60 91 92 
--------
--------- ---------- --------- -----------
MEAN 12.6 58.7 81. 0 93.2 
+ SEM 2.6 3.3 3.8 3.3 
n 7 7 4 4 
Data from n independent experiments. Data shown are the percentage 
inhibition by 20 µM D600 of GnRH- and K+-stimulated LH release in the 
absence of D600. The cells were pre-incubated with D600 for 10 min 
prior to stimulation. Basal release has been subtracted. 
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Table 5: Inhibition of GnRH-stimulated LH release by D600 at 2 
different ca2+ concentrations. 
2+ LH Release (% of control) 0600 Ca 
----------------------------
(µM) (mM) SPIKE Phase Plateau Phase 
(0-3 min) (9-30 min) 
------ ------
------------- --------------
50 1 96.6 68.4 
50 5 100.0 62.4 
Prior to stimulation, the cells were pre-incubated with 50 µM 
D600 for 10 minutes. The data shown is LH release stimulated by 
10-7 M GnRH in the presence of D600, expressed as a percentage of 
GnRH-stimulated release in the absence of channel blocker. Basal 
release was subtracted. 
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was inhibited with a similar potency (IC50 = 0.2 µM). However, the 
spike phase of K+-stimulated LH release required higher concentrations 
of D600 for inhibition (IC50 = 2µM) (Fig.8). 
The ability of D600 to inhibit the plateau phase of GnRH-stimulated LH 
release suggests that VSCC are involved in this phase. However, the 
D600-sensitive portion of the GnRH plateau phase is less than the 
D600-sensitive portion of the K+-stimulated plateau phase This 
indicates that GnRH does not activate all the D600-sensitive VSCCs 
which are activated by K+. 
3.3.2 Inhibition of GnRH-stimulated LH release by nifedipine 
The effects of the VSCC blocker, nifedipine, were both 
qualitatively and quantitatively similar to that of D600. Nifedipine 
had a very small effect on the spike phase, but inhibited the plateau 
phase of GnRH-stimulated LH release more markedly (Fig.9 & 10). The 
doses of nifedipine used and the pre-incubation period were adequate 
since both the spike and plateau phases of K+-stimulated LH release 
were essentially abolished (Fig.10). The potency of nifedipine for 
inhibition of the plateau phase of GnRH-stimulated LH release (IC50 = 
10-8M) was similar to the drug's potency for inhibition of both phases 
of K+-stimulated release (Fig.10). 
3.4 The effect of inorganic ions and ruthenium red 
The results presented in the previous sections showed that in the 
absence 2+ of extracellular Ca , a residual portion of the spike phase 
persisted, while the plateau phase was abolished. In contrast, the 
organic VSCC blockers had little effect on the spike phase while the 
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Effect of Nifedipine on the spike and plateau phases of GnRH-
stimulated LH Release. 
Cells were stimulated with 10-6 M GnRH in the presence(~) or 
absence(()) of 10-5 M nifedipine. In nifedipine-treated cells 
the drug was present 10 minutes before the addition of 
10-6 M GnRH. 
Extracellular ca2+ was 1 mM. This experiment is representative 
of 3 similar experiments. 
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and K+-stimulated LH release. 
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period. ( e, 0 ) Basal; ( •, O ) 1 o-6 M GnRH; ( • , !:::,,. ) 50 mM K+. 
Extracellular ca2+ was 1 mM. This experiment is 
representative of two similar experiments. 
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plateau phase was partially inhibited. This suggested that GnRH 
caused ca2+ entry via route(s) additional to D600/nifedipine-sensitive 
vscc. To characterize the other possible modes of ca2+ entry, the 
effects of a range of divalent cations and other possible ca2+ channel 
blockers were investigated.Thie effects on both the spike and plateau 
phases of GnRH-stimulated LH release were investigated . 
. 2+ 2+ 3+ cd2+ 3.4.1 The effect of Ni ~ ~ , and 
Initially, the effect of an array of inorganic ions of GnRH-
stimulated LH release was investigated. Experiments with some of the 
ions were done once only. Only those those ions which yielded 
interesting data were used in further experiments. The chloride salts 
were used. Nickel, 
release (Table 6b). 
zinc and cadmium inhibited both phases of 
A detailed time course of the effect of cd2+ 
LH 
is 
shown to illustrate its effects (Fig.11). However, these ions also 
non-specifically enhanced basal LH release (Table 6a). La3+ increased 
basal LH release (Table 6a) and also enhanced the spike phase of 
GnRH-stimulated LH release, while it inhibited the plateau phase 
(Table 6b). This increase in basal LH release indicates some action 
of these ions other than simply ca2+ channel blockade. For this 
reason further studies with these particular inorganic ions were not 
pursued. 
3.4.2 The effects of co2+ 
The cation co2+ inhibited both phases of GnRH-stimulated LH 
release, without increasing basal LH release (Fig.12). The IC50 of 
co
2
+ for inhibition of both the spike and plateau phase was 300 µM 
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(Fig.12). To characterize the action of Co2+ further, its effects on 
LH release stimulated by phorbol ester, forskolin, K+ and Ba2+ were 
determined. Phorbol esters are analogues of diacylglycerol which 
activate protein kinase C (Nishhizuka, 1984). Phorbol esters have 
previously been shown to stimulate LH release from chicken pituitary 
cells (Davidson et al., 1987). Forskolin is an activator of adenylate 
cyclase that act by activating the catylytic subunit of adenylate 
cyclase (Seamon 
secretagogue in 
and Daly,1981). Ba2+ ions 
chicken pituitary cells. The 
are a 
action 
previously been characterised by Davidson et al. (1987). 
powerful 
of Ba2+ 
LH 
has 
co
2+ inhibited LH release evoked by high K+ and by Ba2+ (Fig.13). The 
actions of both these stimuli require the involvement of voltage-
sensitive calcium channels (Davidson et al., 1987). In contast co2+ 
had no effect on secretion evoked by either the phorbol ester TPA or 
forskolin (Fig.13). 
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Table 6a Effect of Ni 2 +, zn2+, La3+ and cd2 + on basal LH release in 
the spike and plateau phases. 
Nickel 1 mM 
Zinc 1 mM 
Lanthanum 1 mM 
Cadmium 1 mM 
Fold increase of basal release 
(0-3 min) 
2.22 
1 . 43 
1 . 21 
2.17 ± 0.61 
(9-30 min) 
0.79 
2. 21 
2.73 
1 .84 ± 0.66 
n 
1 
1 
1 
2 
The cells were pre-incubated with the chloride salts of the ions 
for 10 minutes prior to the release period . 
Table 6b . + 2+ 3+ 2+ Effect of Ni , Zn , La and Cd of GnRH-stimulated 
LH release 
Nickel 1 mM 
Zinc 1 mM 
Lanthanum 1 mM 
Cadmium 1 mM 
% of Control 
SPIKE(0-3min) PLATEAU(9-30min) n 
59.57 
9.05 
126.96 
16.75 ± 10.99 
23.25 
0.09 
71 . 78 
-7.32 ± 8.95 
1 
1 
1 
2 
The cells were pre-incubated with the indicated ions for 10 minutes 
prior to stimulation with 10-7M GnRH. The data are presented as a 
percentage of the LH released by GnRH in the absence of the ions. 
Basal release was subtracted. Negative values indicate release below 
basal levels. 
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3.4.3 Effects of Gd3+ 
Gd3+ inhibited both the spike and plateau phases (IC50 = 3 µM 
and 1 µM respectively) of GnRH-stimulated LH release (Fig.14). It 
did not completely block by K+-stimulated LH release, but it did 
abolish Ba2 +-stimulated LH release (Fig. 15). Unlike Co2+, Gd3+ 
interacted synergistically with the protein kinase C activator TPA, 
enhancing the LH releasing ability of (Fig.15). 
3.4.4 Ruthenium Red (RR) 
The polycationic dye, ruthenium red (RR) was investigated as a 
2+ possible Ca channel blocker because of its known inhibitory effects 
on ca
2
+ transport in mitochondria (Carofoli and Crompton, 1978) . RR 
caused a marked inhibition of both phases of GnRH-stimulated LH 
release (Fig.16). A residual portion of the spike phase remained in 
the presence of 100 µM RR, while the plateau phase was abolished by 
this concentration of the compound. 
The inhibitory effect of RR on the spike phase of GnRH-stimulated LH 
release was dependent on the pre-incubation period with RR prior to 
stimulation with GnRH (Fig.17). 
The ability of TPA and forskolin to stimulate LH release were only 
slightly inhibited in the presence of RR (Fig.18). However, RR 
virtually abolished LH release in response to K+ , Ba2+ and 
veratridine, all of which depend on D600-sensitive vscc for their 
activity (Fig.18). 
3.4.5 Effect of Q-conotoxin 
The effect of Q-conotoxin GVIA a specific peptide blocker of a 
class of neuronal VSCC (Rivier et al.,1987) was also investigated. 
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Fig.14 Inhibition of spike (0-3 minutes) and plateau (9-30 minutes) 
phases of GnRH-stimulated LH by Gd3+. 
Gd 3+ was present from 10 minutes prior to stimulation with 
GnRH. The cells were then stimulated for the indicated time 
periods. ( •, 0 ) Basal, ( • , 0) 1 0- 7 M GnRH. Extracellular 
2+ Ca was 1 mM. This experiment is representative of 4 similar 
experiments. 
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Representative of 3 similar experiments. 
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release. 
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3 similar experiments. 
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Q-Conotoxin had no effect on either the spike or plateau phases of 
GnRH-stimulated LH release (Fig. 19). 
3.5 45ca2+ efflux studies 
Many hormones are known to mobilize ca2+ from intracellular 
stores (Berridge, 1984). It was therefore important to characterize 
the effects of of ca2+ channel blockers on intracellular ca2+ 
mobilization by GnRH. 45Ca2+ efflux was used to monitor this 
phenomenon. 
The cells preloaded with 45Ca 2+ for 2 hours, after which they were 
were vigorously washed for 20 minutes (see Methods). During this 
washing period 45Ca2+ is released from the rapidly- exchanging 
intracellular ca2+ pools. The efflux of 45Ca2+ from slowly-
exchanging labelled pools in the cells was then measured during 
consecutive 3 minute intervals. 45 2+ Basal Ca efflux, i.e. the release 
45 2+ . 45 2+ 
of Ca from unstimulated cells, reflects the release of Ca from 
a slowly exchanging kinetic compartment with half-life= 35-70 minutes 
(Fig.20). 
. 45 2+ In Table 7, the results obtained in a typical Ca efflux experiment 
are shown. These results are typical of 19 experiments comparing 
basal efflux to GnRH-stimulated 45ca2+ efflux. There are 6 efflux 
periods. The counts remaining inside the cells at the end of the 
experiment are marked "cells". The fractional efflux was calculated 
for each well seperately in a set of triplicate wells. The mean± SEM 
fractional efflux of triplicate wells were calculated for each efflux 
period. . 45 2+ These results were plotted as fractional Ca efflux versus 
time. The data in Table 7 are shown to illustrate typical values 
obtained and how the fractional efflux values were calculated. 
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Fig.20 Effects of a GnRH antagonist on GnRH-stimulated 45ca2+ efflux. 
10-5 M GnRH antagonist (Ac-O-Nal-Me-4-CIPHE-O-Trp-Ser-N-
Isopropyl Lys-D-Tyr-Leu-Arg-Pro-D-AlaNH3) was present from t = 
-6 min and 10-7M GnRH was added at t = 0 min. This 
experiment is representative of 3 similar experiments. 
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Table 7: Data from a . 45 2+ typical Ca efflux experiment (PTO for legend) 
Efflux CPM F.E F.E. 
Period (mean + S.E.M.) 
-(min) 
Basal 
0-3 4374 5. 1 5 5.38 + 0. 1 2 
-4591 5.47 
4429 5.54 
3-6 3384 4. 17 4.40 + 0.20 
-
3370 4.21 
3647 4.80 
6-9 3101 3.98 3.93 + 0.03 
-2999 3.90 
2836 3.90 
9-12 2449 3.26 3.44 + 0.22 
-
2362 3 .19 
2712 3.88 
12-15 2357 3.24 3. 31 + 0. 10 
-2286 3. 18 
2368 3.51 
15-18 2081 2.95 2.94 + 0.03 
-2011 2.89 
1940 2.97 
Cells 69398 
68643 
64294 
Efflux CPM F.E F.E. 
Period (mean ± S.E.M) 
(min) 
GnRH 
0-3 4475 5.42 5.66 ± 0.28 
4446 5.33 
5217 6.22 
3-6 3556 4.53 4.34 ± 0.27 
3026 3.80 
3715 4.68 
6-9 2995 3.98 3.83 ± 0. 12 
2763 3. 61 
2961 3.90 
9-12 5170 7.27 7.02 ± 0. 16 
4907 6.73 
5087 7.07 
12-15 4272 6.43 6 .15 ± 0. 16 
4187 6. 12 
3968 5.88 
15-18 2917 4.64 4.82 ± 0.09 
3178 4.91 
3135 4.90 
Cells 61378 
63107 
62347 
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Table 7: The data displayed in this table are data obtained in a 
typical 45ca2+ efflux experiment. After the cells were 
45c 2+ loaded with a , they were rigorously washed so that 
only 45ca2+ effluxing from a slowly turning-over pool 
remained. This wash period was followed by six efflux 
periods. At the end of the experiment the cells were lysed 
to determine the radioactivity remaining in the cells. 
Each experiment was done in triplicate. The radioactivity 
effluxed during the six efflux periods and the radio 
activity present in the cells at the of the efflux periods 
are shown after subtraction of the machine blank (40 CPM). 
The fractional efflux (F.E) for each well was calculated as 
described in section 2.5. 
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GnRH stimulated a 1.74 ± 0.05 (mean± S.E.M.) fold increase in 45ca2+ 
efflux during the first 3 minutes after its addition, in 10 
independent experiments (Table 8). Th · · · 45c 2+ ffl is increase in a e ux is 
a GnRH-receptor mediated event, since it was inhibited by a GnRH-
antagonist (Fig.20). Thyrotropin releasing hormone (TRH) also 
stimulated 45ca2+ efflux (Fig.21). Corticotropin releasing factor 
(CRF), vasopressin and dopamine did not produce this effect (Fig.21) 
. 45 2+ GnRH-stimulated Ca efflux was not dependent on extracellular Ca2 + 
since it was not inhibited when the cells were stimulated in ca2+-free 
medium ( no chelator) (Fig.22). Similarly, Gd3+ had no effect 
GnRH-stimulated 45ca2+ (Fig.23 ). RR caused a slight inhibition 
on 
of 
45 2+ . GnRH stimulated Ca efflux (Fig.24). 
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Table 8: GnRH-stimulated 45ca2+ efflux: results from 10 independent 
experiments. 
------------------------------------------------------
EX NO BASAL GnRH FOLD STIMULATION 
-----
--------------- -------------- ------------------
E 1 4.05 6.60 1 . 63 
E 3 4.05 7.70 1 . 90 
E 4 4.00 6.93 1 . 7 3 
E 5 4.00 6.73 1. 66 
E 8 6.00 11. 60 1. 93 
E 7 4.70 7.73 1. 64 
E 9 4.57 9. 13 2.00 
E 12 4.80 8.45 1 . 76 
E 20 3.73 5.74 1 . 54 
E 21 3.44 5.11 1. 49 
------
--------------- -------------- ------------------
MEAN 4.33 7.57 1 . 7 4 n=10 
± SEM ± 0.23 ± 0.59 ± 0.05 
Basal and GnRH-stimulated fractional 45ca2+ efflux(% per 3 min) for 
the first 3 minutes after the addition of GnRH (10- 7 M) are presented. 
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Fig.21 45ca2+ efflux from cultured chicken pituitary cells. Effects 
of GnRH, TRH, CRF, vaspressin, and dopamine 
The test substances were added at t = 0 min. This experiment 
is representative of 3 similar experiments. 
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Fig.22 
12 
0-O fWiAI.. (1 mM ea2+) 
• - • GnRH (1 mM ea2+) 
1:::,,. -1:::,,. fWiAI.. (" ea2+ -free ") 
J,,. - J,,. GnRH (" ea2+ -free ") 
4 L_--1...6--~3 __ ...... o __ _J3 ___ 6~--9-::----
Time , minutes 
2+ 45 2+ The effect of Ca removal on GnRH-stimulated 
Ca efflux. 
The medium was replaced with ca
2+-free medium (without EGTA), 
at t = -6 min and 10-
7 GnRH was added at t = 0 min. This 
experiment is representative of 3 similar exp
eriments. 
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Fig.23 The effect of Gd
3
+ on GnRH stimulated 45ca2+ efflux. 
3+ 
Gd was present from t = -6 min and 10-
7 M GnRH was added at 
t = 0 min. Representative of 3 similar experi
ments. 
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. 45 2+ The effect of ruthenium red on GnRH stimulated Ca efflux. 
Ruthenium Red was present from t = -6 min and 10-7 M GnRH was 
added at t = 0 min. Representative of 3 similar experiments. 
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Part 2: INVESTIGATION OF THE ROLE OF CYCLIC AMP IN GnRH-STIMULATED 
LH RELEASE 
4.1 The effects of forskolin, IBMX and dibutyryl cAMP on LH release 
Forskolin, an activator of adenylate cyclase (Seamon et al., 
1981), stimulated LH release from chicken pituitary cells (Fig.25). In 
3 independent experiments, the concentration of forskolin giving half 
maximal stimulation varied between 2.5 and 10 µM. 1-Methyl-3-
isobutyl-xanthine (IBMX), a CAMP phosphodiesterase inhibitor, 
stimulated a small increase in LH release on its own and enhanced 
forskolin-stimulated LH release (Fig.25). At higher concentrations 
than required to stimulate LH release, forskolin elevated the cellular 
cAMP concentration (Fig.25). Similar to its effect on forskolin-
stimulated LH release, IBMX enhanced the ability of forskolin to 
elevate the concentration of cellular cAMP (Fig.25). The stimulatory 
effect of the cAMP analogue dibutyryl-cAMP (dBu-cAMP) on LH release 
was poor in comparison to forskolin- and IBMX-stimulated LH release 
(Fig.26). 
4.2 The kinetics forskolin-stimulated LH release 
The onset of forskolin-stimulated LH release was rapid, with 
maximal secretion occuring within the first 20 minutes of exposure to 
the drug (Fig.27). The stimulatory effect of forskolin was prolonged, 
lasting up to 100 minutes which was the longest period tested 
(Fig.27). An analysis of the very early time course of forskolin 
stimulation was undertaken in 3 experiments, which are summarized in 
Table 9. The stimulatory effect of forskolin was detectable within the 
first 3 minutes of exposure. However forskolin did not show the 
initial transient spike phase of release which is characteristic of 
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Fig.25 Forskolin dose-response curve: effects on LH release and 
cellular cAMP, in presence and absence of IBMX. 
The cells were stimulated for 20 min. The LH released during 
the 20-min period is shown in A. The cAMP present in the 
cells at the end of the stimulation period is shown in B. 
( • ) No IBMX, ( +) IBMX ( 0. 5 mM) present during stimulation 
period. This is representative of 2 similar experiments. 
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Fig.27 Kinetics of forskolin and K+-stimulated LH release. 
Solid bars, basal; hatched bars, forskolin (10 µM); dotted 
bars, K+ (60 mM). Forskolin and K+ were present continuously 
from t = 0 tot= 100 minutes. The medium was replaced with 
fresh medium at 20-minute intervals. 
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Table 9: Time-course of Forskolin-stimulated LH release: 
comparison with GnRH and phorbol ester 
------------------------------------------------------------
EX NO Time Period Basal GnRH Forskolin TPA 
-------
------------- ---------
--------
-----------
-------
98 0-3 min 2.49 34.4 5.54 
116 3.93 47.4 6.91 2.95 
121 1. 93 49. 1 2.63 7.20 
MRR 2.78 43.6 5.02 5.08 
± SEM ± 0.84 ± 6.6 ± 1 . 78 ±2. 1 
-------
------------- ---------
--------
-----------
-------
98 3-9 min 3.40 25.9 14.56 
1 1 6 1 . 17 1 1 . 3 8.72 9.02 
1 21 2. 16 19. 1 10.9 33.2 
MRR 1 . 12 9.4 5.7 10.6 
± SEM ± 0.32 ± 2. 14 ± 1. 01 ± 7.46 
-------
------------- ---------
-------- -----------
-------
98 9-30 min 9.08 51.8 60.0 
116 7.60 32.2 31 . 7 38.5 
1 21 5.94 34.8 63.4 141 . 0 
MRR 1. 08 5.66 7.39 12.8 
± SEM ± 0. 13 ± 1 . 08 ± 0.58 ± 7.3 
------------------------------------------------------------
MRR = Mean release rate (ng/pituitary equivalent/3 min). 
The cells were stimulated for the time-periods indicated. The medium 
was replaced with fresh medium at the start of each time-period 
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GnRH stimulation (Table 9). The time course of forskolin stimulation 
was similar to that produced by phorbol ester (Table 9). In 
comparison to the kinetics of forskolin-stimulated LH release, K+-
stimulated LH release showed a more transient spike phase, followed by 
a slow decline (Fig.27). 
4.3 ca2+ dependence of forskolin-stimulated LH release 
Some of the effects of cAMP are known to be mediated by the 
cAMP-dependent phosphorylation of calcium channels with a subsequent 
increase in cytosolic ca2+ (Tsien, 1983; Catterall, 1988). Effects 
mediated via this mechanism should be entirely dependent on the 
presence of extracellular ca2+. The ca2+ dependence of forskolin-
stimulated LH release was therefore investigated. LH release due to 
forskolin was largely independent of extracellular ca2+ since it was 
only slightly inhibited in ca2+-free medium with or without the ca2+ 
chelator EGTA (Fig.28). This was in contrast to K+-stimulated LH 
2+ release which was abolished, as expected, in the presence of Ca -free 
medium (Fig.28). 
4.4 Effect of GnRH on cellular cAMP concentration 
Cellular levels of cAMP were found to be highly variable between 
experiments (Table 10). However in each of the 4 experiments GnRH 
consistently stimulated an increase in cellular cAMP (Table 10). In 
cells stimulated for 1 hour, the mean increase in cAMP levels was 1.33 
± 0.20 fold. 
4.5 Synergistic reaction of GnRH with forskolin 
In addition to activating adenylate cyclase directly, forskolin 
has also been reported to interact synergistically with hormones which 
75 
_J 
0 
0::: 
1-
z 
100 A 
A 
O 50 
u 
LL 
0 
~ 
0 
Forskolin 1 Oµm 
Fig.28 ca
2
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the presence of (A) 1 mM ca2+ (B) ca2+ free medium (no added 
2
+) d ( ) 0 5 ' C 2 + f d. h 11 Ca an C . mM EGTA 1n a - ree me 1um. Te ce s were 
pre-incubated in these media for 10 minutes, then stimulated 
for 20 min. 
percentage 
2+ Release in Ca -free media is expressed as a 
of that in medium containing 1 
Representative of 3 similar experiments. 
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mM C 2+ a . 
Table 10: The effect of GnRH on the cellular cAMP concentration. 
Results of 4 experiments. 
EX NO STIMULATION BASAL GnRH 10-7M FOLD STIM 
156 
172 
179 
180 
PERIOD (cAMP pmol/pit. equiv.) 
1 hr 11 . 80 19.4 
3 hr 4.25 11 . 5 
6 hr 4.42 8.4 
10 min 1. 27 2.06 
1 hr 1 . 52 1. 96 
1 hr 1 . 98 2. 16 
1 hr 1. 50 1. 96 
1.64 
2.71 
1 . 56 
1. 62 
1 . 29 
1. 09 
1. 31 
The cells were stimulated for the indicated time periods and, at the 
end of the stimulation period the cAMP in the cells was extracted, and 
the cAMP concentration of the samples was determined by 
radioimmunoassay (see section 2.2). 
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activate adenylate cyclase (Nelson and Seamon, 1986). This latter 
effect occurs at very much lower concentrations of forskolin (10 to 
100 nM) than required for direct activation (10 µM) of adenylate 
cyclase (Nelson and Seamon, 1986). Therefore the effect of forskolin 
at concentrations between 10-10 Mand 10-7 Mon GnRH -stimulated LH 
release was investigated. 
In a previous section, it was shown that GnRH stimulates LH release in 
a biphasic manner with a distinct spike phase (0-30 min) followed by a 
sustained plateau phase (9-30 min) (Fig.1). The spike phase of GnRH-
stimulated LH release was not affected by co-stimulation with low 
doses of forskolin (Fig.29). However, the plateau phase was enhanced 
in the presence of these low doses of forskolin (Fig.29). The absence 
of any notable effect of forskolin on the spike phase could be because 
the cells were exposed to forskolin for too short a period of time (3 
minutes). Forskolin at higher concentrations (10 µM) also interacted 
synergistically with GnRH to stimulate LH release (Fig.30). However, 
although forskolin augmented GnRH-stimulated LH release, it did not 
alter the EC50 of GnRH (Fig.30). 
4.6 The effect of forskolin on GnRH-stimulated 45ca2+ efflux 
As demonstrated earlier in Part 1, GnRH stimulates 45ca2+ efflux 
from a slowly turning over intracellular ca2+ pool. In order to gain 
insight into the mechanism of the synergism between GnRH and 
the effect of forskolin on GnRH-stimulated was forskolin, 
examined. In the presence of forskolin, the basal rate of 45ca2+ 
efflux was raised (Fig.31). Forskolin had no effect on GnRH-
. 45 2+ 
stimulated Ca efflux (Fig.31). This indicates that forskolin does 
not augment GnRH-stimulated LH release by enhancing its ability to 
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Fig.29 Effect of low concentrations of forskolin on the spike phase 
(0-3 min) and plateau phase (9-30 min) of GnRH stimulated LH 
release, and on basal release. 
(•>Basal (0-3 min), (O) 10-?M GnRH (0-3 min) 
(O) Basal (9-30min), (.6.) 10-?M GnRH (9-30min). 
The cells were pre-incubated with forskolin for 3 mins prior 
to the stimulation period. 
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Fig.31 The effect of forskolin on GnRH stimulated 45ca2+ efflux. 
Forskolin (10 µM) was present from t = -6 min and GnRH (10-7M) 
was added at t = 0 min. This experiment is representative of 2 
similar experiments. 
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mobilise stored intracellular ca2+. 
4.7 The effect of forskolin on GnRH-stimulated inositol phosphate 
production 
One of the signalling systems activated by GnRH is inositol 
phospholipid breakdown. A possible mechanism by which forskolin could 
enhance GnRH-stimulated LH release (Section 4.5) might be via 
enhancement of this signal. The effect of forskolin on GnRH-stimulated 
inositol phosphate (IP) production was therefore investigated. Total 
IP accumulation in Li+-treated cells after 30 min of GnRH stimulation 
was determined, as this provides an easily-measured index of inositol 
phospholipid breakdown. 
GnRH stimulated a 1.49 ± 0.16 fold increase in total inositol 
phosphate production in 3 independent experiments (Fig.32). In the 
presence of forskolin, the increase in inositol phosphate production 
due to GnRH was decreased slightly to 82.6 ± 24.5 % (n=3) of the 
increase in the absence of forskolin (Fig.32). Forskolin did not 
significantly alter unstimulated inositol phosphate levels (Fig.32). 
Therefore it appears that the synergism between GnRH and forskolin 
seen at the level of LH release is not due to an enhancement of the 
effect of GnRH on inositol phosphate production. 
4.7 The interactions between cAMP, ca2+ and protein kinase C 
The results from the previous sections indicated that the 
observed synergism between forskolin and GnRH could not be accounted 
for by enhanced inositol phospholipid breakdown or ca2+ mobilisation. 
It seemed possible that forskolin might exert its synergistic action 
at a more distal step in the signalling cascade leading to LH release. 
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The interactions between forskolin and two pathways that are known to 
be activated by GnRH, namely ca2+ and protein kinase C, were therefore 
investigated. Forskolin was tested in combination wi~h 
secretagogues that increase the cytsolic ca2+ concentration: 
three 
ca2+ 
ionophore A23187, veratridine, and 50 mM K+. Forskolin interacted 
synergistically with all 3 these stimuli, as shown in Fig 33 which 
depicts 2 representative experiments. Synergism between forskolin and 
A23187 was consistently observed in 4 experiments, and between 
forskolin 
interacted 
pituitary 
and veratridine in 3 experiments. In addition, 
synergistically with Ba2+ (Fig.30), which 
forskolin 
cells via 2+ Ca channels and "substitutes" 
enters 
for ca2+ 
the 
in 
stimulating LH release (Davidson et al., 1987). 
The phorbol ester TPA, an activator of protein kinase C, also 
interacted synergistically with forskolin to stimulate LH release 
(Fig.33). Synergism between forskolin and TPA was observed in 7 
experiments. A "three-way" synergism resulted when forskolin, 
veratridine and TPA were used simultaneously to stimulate LH release 
(Fig.34). These results suggest that cAMP interacts with GnRH at a 
site distal to the activation of the ca2+ and protein kinase C 
pathways. 
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Fig.34 "Three-way" synergism between cAMP, ca2+ and protein kinase C. 
The cells were stimulated with each secretagogue or 
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5. DISCUSSION 
ca2+ is known to play an important role in the mechanism by which 
GnRH stimulates LH release. An increase in cytosolic ca2+ levels 
activates a secretory response in a variety of cell types. The 
2+ activation of a secretory response by Ca -dependent hormones has been 
shown to involve the mobilization of intracellular ca2+ and/or the 
entry of 2+ extracellular Ca . The relative importance of these two 
sources of ca2+ is thought to vary in different cell types and for 
different exocytotic processes. Also, the routes by which 
2+ extracellular Ca enters cells, may vary depending on the cell type. 
Kinetic studies in this thesis demonstrated that GnRH stimulates LH 
release from chicken gonadotropes in a biphasic manner. The spike 
phase of LH release was shown to be largely dependent on the entry of 
extracellular ca2+ (± 90%). The plateau phase of LH release was 
totally dependent on extracellular C 2+ a . Early experiments 
investigating the mechanism by which GnRH stimulated the entry of 
extracellular ca2+, reported that GnRH stimulated ca2+ entry via D600-
sensitive ca2 + channels (Hopkins and Walker, 1978; Borges et al., 
1980; Conn and Rogers, 1980). In contrast to this, the VSCC blockers 
that belonged to the class, dihydropyridines (DHP), were reported to 
be ineffective in inhibiting GnRH-stimulated LH release (Conn et al., 
1983). More recently, Chang et al. (1986), reported that 
nitrendipine, a DHP, inhibited GnRH-stimulated LH release. This thesis 
demonstrates that the plateau phase of GnRH-stimulated LH release in 
the chicken gonadotrope can be partially inhibited by the DHP 
nifedipine. This suggested that the VSCC in rat and chicken 
gonadotropes played a partial role in LH release during the plateau 
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phase. 
In this study the role of VSCCs in the chicken gonodotrope was 
determined by examining the effects of the VSCC blockers D600 and 
nifedipine on the spike and plateau phases of GnRH-stimulated LH 
release. The spike phase of LH release was found to be independent 
of the activation of VSCCs that could be inhibited by D600 and 
nifedipine whereas approximately 50% of the plateau phase was 
2+ dependent on Ca entry via these VSCCs. 
2+ Since the spike phase is not dependent on Ca entry via VSCCs ,the 
2+ question is posed as to the nature of extracellular Ca entry and the 
2+ role of Ca and the other known second messengers in this phase of 
GnRH-stimulated LH release. GnRH activates the hydrolysis of PIP2 in 
the chicken (Davidson et al., 1987; and Fig. 32) and in the rat 
(Kiesel and Catt, 1984; Andrews et al., 1986; Noar et al., 1986) 
gonadotrope. IP3 and DAG, the resulting products, are responsible for 
the mobilization of stored intracellular ca2+ and the activation of 
protein kinase C respectively (Berridge et al., 1984). This appears 
to be one of the initial events that occurs once GnRH has bound to its 
receptor since an increase in IP3 is seen within seconds (Kiesel and 
Catt, 1984). 
It is, therefore, feasible that the production of IP3 which leads to 
the mobilization of stored intracellular ca2+ may give rise to the 
residual LH release during the spike phase apparent in the absence 
2+ of extracellular Ca . The experiments conducted suggest that this 
residual release is due to the mobilization of intracellular ca2+ 
stores since : (1)depletion of the intracellular ca2+ by pretreatment 
with EGTA and A23187 abolishes all of the spike phase of release; 
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45 2+ . 2+ (2)GnRH- stimulated Ca efflux from slowly turning over Ca pools 
2+ is not inhibited by the removal of extracellular Ca ; and (2) GnRH is 
able to stimulate an increase in inositol phosphate production. 
Since the removal of extracellular partially ca2+ inhibited the spike 
phase, the mechanism by which extracellular ca2+ enters the 
gonadotrope was futher investigated by examining the effects of 
2+ inhibitors of extracellular Ca entry on GnRH-stimulated LH release. 
A range of inorganic ions was tested in an attempt to find an 
inhibitor 2+ of the route via which Ca entered the gonadotrope which 
was insensitive to blockage by 0600 and nifedipine. Several of these 
cations tested e.g. cd2+, Ni 2+, zn2+ and La3 + inhibited both the 
spike and plateau phases. However, they also increased basal LH 
release. The mechanism by which these ions induced LH release on 
their own is not known ,but it might be similar to that of cu2+ ions 
which are thought to stimulate LH release by interacting with the GnRH 
receptor (Schwartz and Hazum, 1986). Two other ions tested, co2+ and 
Gd 3+, did not increase LH release on their own but appeared to have 
non-specific effects besides the inhibition of ca2+ entry. 
interacted with secretagogues that stimulated LH release by a 
They 
C 2+ a -
independent manner and were inconsistent in their ability to inhibit 
ca
2
+ entry via VSCC that were activated by K+. Therefore, an 
inhibitor that only blocked the entry of extracellular ca2+ and did 
not interact with secretagogues that activated other intracellular 
events was sought. 
The polycationic dye ruthenium red (RR) has been reported to inhibit 
several ca2+ transport processes including mitochondrial ca2+ uptake 
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(Carafoli et al., 1978) and the ca2+ release channel of the 
sarcoplasmic reticulum (Smith et al., 1985). In the present study, RR 
inhibited both the spike and plateau phases of GnRH-stimulated LH 
release and did not increase basal LH release. The pattern of RR 
inhibition on the spike and plateau phases was similar to the effect 
of the removal of extracellular ca2+ on GnRH-stimulated LH release. 
Also, unlike the cations tested, RR did not significantly affect 
stimulation of LH release by the protein kinase C activator, TPA, and 
the adenylate cyclase activator, forskolin. This was expected since 
both these secretagogues are capable of stimulating LH release 
independently 2+ of extracellular Ca . In additon, RR did not inhibit 
GnRH-stimulated 45ca2+ efflux indicating that it did not affect 
immediate post-receptor events. This, together with the fact that RR 
did not appear to affect the whole exocytotic process, since it did 
not affect TPA- and forskolin-stimulated LH release, suggested that RR 
was acting at an extracellular site. 
RR blocked the entry of ca2+ via VSCC, since it inhibited both K+- and 
veratridine-stimulated LH release. Ba2+ is known to elicit LH release 
by entry through VSCC (Smith et al., 1987). Ba2+-stimulated release 
was also inhibited by RR. These three secretagogues require the entry 
of either ca2+ or Ba2+ via VSCC which can be blocked by D600 and 
nifedipine to stimulate LH release from gonadotropes. Therefore, it 
is evident that RR inhibits ca2+ entry via VSCC. However, RR appears 
to inhibit an additional ca2+ entry mechanism, because unlike D600 and 
nifedipine it inhibits the spike phase of secretion. This pattern of 
inhibition is similar to the removal of extracellular ca2+. Since RR 
has a large molecular size and is hydrophilic because of its 
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polycationic structure, it is unlikely that it crosses the plasma 
membrane to act at an intracellular site. This view was supported by 
observations that it did not inhibit the effects of secretagogues that 
ca
2+-independent intracellular events, e.g. TPA and activate 
forskolin. This suggested that the inhibition of the spike phase by 
RR was due to the inhibition of ca2+ entry through the non-VSCC 
mechanism. 
Both organic VSCC blockers tested, D600 and nifedipine, inhibited the 
plateau phase of secretion by approximately 50%. However, the removal 
of extracellular ca2+ or treatment with RR completely inhibited the 
plateau phase. Some of the inorganic ions also inhibited the plateau 
phase to a similar extent. These findings indicate that in addition 
to ca2+ entry via VSCC during the plateau phase, ca2+ also enters 
2+ through a non-VSCC. This route of Ca entry can be blocked by RR and 
is active in both the spike and plateau phases of GnRH-stimulated LH 
release whereas VSCC are only active in the plateau phase. 
The mechanism by which this additional route of ca2+ entry is 
activated is not known. What is apparent is that this route of ca2+ 
entry is insensitive to inhibition by organic VSCC blockers. This 
would suggest that this route of ca2+ entry is not activated by 
membrane depolarisation, since K+-stimulated LH release was completely 
inhibited by these organic VSCC blockers. Three types of neuronal 
VSCC have been characterized (Nowycky et al. 1986; Miller, 1987) . 
Two of these classes of VSCC are insensitive to inhibition by organic 
VSCC blockers with the other being sensitive to inhibition by the 
organic VSCC blockers. It is, therefore, possible that the additional 
2+ 
route of Ca entry present in the chicken gonadotrope might be one of 
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the VSCC described in neurones that is insensitive to organic VSCC 
blockers. However, this appears to be unlikely since K+-stimulated LH 
release, which is assumed to activate all VSCC in the gonadotrope, is 
completely abolished in the presence of organic VSCC blockers. 
Another possibility for the additional route of ca2+ entry is that of 
2+ a "receptor-operated" Ca channel (ROCC). ROCC have been postulated 
in many cell types and several different types of ROCC have been 
identified electrophysiologically. ROCCs activated by IP3 have been 
identified in T lymphocytes (Kuna and Gardner, 1987). In addition 
inositol-(1,3,4,5)-tetrakisphosphate has been demonstrated to activate 
ROCC in sea urchin eggs (Irving and Moor, 1986). 2+ Furthermore, a Ca -
activated ca2+ channel has been described in neutrophils (von Tchanner 
et al., 1986), and in smooth muscle cells a ca2+ channel that is 
activated by an ATP receptor without requiring any intracellular 
second messenger has been reported (Benham and Tsien, 1987). 
Another model to explain the stimulation of ca2+ influx by ca2+-
dependent agonists is the capacitative model proposed by Putney 
(1986). In this model, an IP3-sensitive pool exists within the cell. 
This IP3-sensitive pool is assumed to be a portion of the endoplasmic 
reticulum which is close to the plasma membrane and which supplies the 
ca
2
+ for exocytosis. Because of its proximity to the plasma membrane, 
this pool is replenished with ca2+ directly from the extracellular 
space. Therefore, inhibition of secretion occurs in the absence of 
t 11 1 C 2+ s· th' C 2+ 1 . 1 . h t ex race u ar a . 1nce 1s a poo requires rep en1s men from 
the extracellular ca2+ pool, maximal inhibition due to the removal of 
extracellular ca2+ is not immediate and is dependent on the length of 
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time the cells have been pre-incubated in ca2+-free medium prior to 
stimulation with the agonist. RR, co2+ and Gd.3+ could act by blocking 
replenishment of this pool, and similarly the degree of inhibition by 
these inhibitors would also be dependent on the length of pre-
incubation time. The data presented for GnRH effects in this thesis 
in relation to the dependence of pre-incubation time of the effects of 
ca
2+ removal and RR are consistent with this model and suggest that 
this pool has a t! = 0.5 to 1 minute. Due to its short half-life, 
this pool cannot be studied . 45 2+ using the Ca technique, but it does 
illustrate that 2+ Ca pool is different from the Ca 2+ pool (t! = 35-70 
45 2+ . 
minutes) studied using the Ca technique. However, even though the 
data presented are compatible with this capacitative model, it is not 
possible to exclude the possibility that the effects seen could be due 
2+ to the extracellular Ca trapped in the glycocalyx or in an unstirred 
layer adjacent to the plasma membrane. This would be compatible with 
2+ Ca entry into the cytosol directly via a channel. 
In non-muscle cells, e.g. gonadotropes, in which receptor activation 
is coupled to the generation of IP3, the intracellular target of IP3 
has been suggested to be the endoplasmic recticulum (ER) (Berridge and 
Irving, 1984) . However, no conclusive proof of the IP3-sensitive 
storage properties of the ER has been given. Recent data have 
suggested that the "calciosomes", which are discrete ca2+-binding 
cytoplasmic organelles, might be the intracellular target of IP3 
(Volpe et al., 1988). 
In addition to investigating ca2+ entry mechanisms involved in GnRH-
stimulated LH release, the role of cAMP as a second messenger in GnRH-
stimulated LH release was examined. Forskolin, which activates the 
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catalytic subunit of adenylate cyclase,and increases cellular cAMP 
levels, stimulated LH release from chicken gonadotropes. In addition, 
IBMX, a cAMP phosphodiesterase inhibitor, which inhibits the 
degradation of cAMP thereby resulting in an accumulation of cAMP 
within cells, also stimulated LH release. The cAMP analogue dBu-cAMP 
also stimulated the release of LH. Its effect was small in comparison 
to forskolin-stimulated LH release. This may be due to an inability of 
dBu-cAMP to efficiently cross the plasma membrane of the gonadotrope. 
It has been reported that dBu-cAMP interacts directly with the GnRH 
receptor thereby stimulating LH release (Smith et al., 1982). This, 
together with a possible permeability problem, would have made 
interpretation of data in which dBu-cAMP was used difficult. Further 
studies with dBu-cAMP were therefore discontinued and forskolin was 
used as the primary tool to examine the role of cAMP in LH release 
from the chicken gonadotrope. Forskolin both increases the cellular 
cAMP levels and stimulates LH release (Fig. 25). Since a mixed 
pituitary cell culture preparation was used in these studies, an 
increase in the cellular cAMP levels is representative of an increase 
in the cellular cAMP of all the cell types present. However, an 
increase in LH release is specific for gonadotropes. 
In the chicken, the stimulatory effect of forskolin on LH release was 
rapid in onset but prolonged. Release of LH occurred within minutes 
after the cells had been exposed to forskolin. In previous studies, 
in which the temporal aspects of forskolin-stimulated LH release in 
rat gonadotropes were investigated (Turgeon and Waring ,1986), there 
was only a slight difference in the secretion rate between control and 
forskolin-stimulated cells and a significant increase in secretion 
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rate occurred only 70 minutes after exposure to forskolin. In the 
original studies by Cronin et al. (1983 and 1984), a similar delayed 
effect of forskolin on LH secretion from rat gonadotropes was 
reported. However, in a recent study by the latter group, LH release 
was reported to be evident within 5 minutes after exposure to 
forskolin (Evans et al., 1985). These data are similar to the data 
obtained in the chicken where the effect of forskolin is maximal in 
the first 20 minutes after which the rate of LH release diminishes. 
Forskolin stimulates LH release on its own and potentiates the action 
of GnRH in both chicken (Fig.30) and rat (Cronin et al., 1983 and 
1984; Evans et al., 1985; Turgeon and Waring, 1986) gonadotropes. 
An unusual phenomenon reported by Turgeon and Waring (1986), was that 
the enhancement of GnRH-stimulated LH release was less at 10 µM 
forskolin than at a dose of 1 µM. 
It has been reported that forskolin has more than one mode of action 
depending on the dose at which it is used. 
using human platelet membranes, found 
Nelson and Seamon (1986), 
that forskolin bound to 
adenylate cyclase at two binding sites for which it had different 
affinities. It binds to a low affinity site (in the µM range) which 
is responsible for the direct activation of adenylate cyclase and a 
high affinity site (Kd = 20 nM) which is responsible for forskolin's 
synergistic interaction with hormones. Similarly, Khanum and Dufau 
(1986), using rat testicular Leydig cells, demonstrated that forskolin 
at concentrations of 1-10 µM, directly activates adenylate cyclase, 
stimulating cAMP production and testosterone release. However, at 
lower doses, where forskolin did not affect cAMP production and 
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stimulate testosterone release, it caused on increase in sensitivity 
to hormonal stimulation of testosterone production. This ability of 
forskolin to bind to adenylate cyclase at more than one site does not 
appear to play a major role in regulating forskolin's ability to 
stimulate LH release or augment GnRH-stimulated LH release. Over a 
range 
only 
of low doses at which forskolin was tested (Fig.29), there was 
-9 one dose, 10 M, at which forskolin enhanced GnRH-stimulated LH 
release and did not stimulate LH release alone. At doses lower than 
this, forskolin had no effect on basal or GnRH-stimulated LH release, 
whereas, at high doses, it stimulated LH release on its own and 
enhanced GnRH-stimulated LH release. 
How does forskolin interact with GnRH to enhance GnRH-stimulated LH 
release? Possible sites at which forskolin interacts with GnRH could 
be at the level of: (1) the GnRH receptor; (2) inositol phosphate 
metabolism; (3) intracellular ca2+ mobilization; (4) activation of 
protein kinase C; and (5) activation of the ca2+ second messenger 
system. 
In the presence of forskolin, the ECso of GnRH-stimulated LH release 
was unchanged. This suggested that forskolin only enhanced the 
ability of GnRH to stimulate LH release without apparently increasing 
the affinity of GnRH for its receptor. It would be expedient to 
provide data conerning the ability of GnRH to bind to the GnRH 
receptor in the chicken gonadotrope in the absence and presence of 
forskolin. However, attempts to establish a reproducible receptor 
binding assay using cultured chicken pituitary cells have been 
unsucessful, and this was thus not possible. Therefore, although it is 
not possible to totally exclude the possibility that forskolin may 
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interact with the GnRH receptor, it does not seem likely. 
One of the immediate post-receptor events that occurs once GnRH has 
bound to its receptor, is the activation of phospholipase C which 
hydrolizes PIP2 into DAG and IP3 (Davis et al., 1986). This is one of 
the early events resulting from the action of GnRH since an increase 
in inositol phosphates can be seen within seconds after stimulation of 
gonadotropes with GnRH (Naor et al., 1986 and Davidson et al.,1987). 
Forskolin did not enhance the ability of GnRH to stimulate an increase 
in total inositol phosphates (Fig.32). An increase in total inositol 
phosphates is assumed to be representative of an increase in IP1, IP2 
and IP3. However, IP1 is the main species present, since the 
experiments were done in the presence of Li+, which inhibits inositol-
1- phosphatase, resulting in the accumulation of IP1. The absence of 
any effect of forskolin on GnRH-stimulated inositol phosphate 
production suggests that the synergism between GnRH and forskolin, 
seen at the level of LH release, is not due to an interaction 
occurring at this level of GnRH action. 
IP3, one of the products of the phospholipase C hydrolysis of PIP2, is 
thought to stimulate 
intracellular ca2+ pools. 
the mobilization of ca2+ from stored 
This mobilization of intracellular ca2+ is 
another event that appears to occur immediately after GnRH has bound 
to its receptor, since an increase in cytosolic ca2+ concentration, 
due to the release of ca2+ from intracellular stores, is evident 
within seconds after GnRH addition (Limor et al.,1987). In this study 
the mobilization of stored intracellular ca2+ was monitored 
investigating the ability of GnRH to stimulate 45ca2+ efflux from 
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by 
a 
2+ 
slowly turning over Ca pool. Forskolin, in the absence of GnRH, 
raised basal levels of 45ca2+ efflux. This increase in 45ca2+ efflux 
could be due to an effect of forskolin on another pituitary cell type 
(eg. lactotropes) and does not necessarily reflect an increase in 
45 2+ Ca efflux from gonadotropes. Forskolin did not enhance the ability 
of GnRH to mobilize stored intracellular ca2+. This, together with 
the evidence that forskolin does not enhance the ability of GnRH to 
stimulate an increase in inositol phosphate metabolism, suggests that 
forskolin does not interact with GnRH at these early sites of GnRH 
action. 
This thesis also determined whether or not forskolin was able to 
interact with other second messengers to stimulate LH release. GnRH is 
known to stimulate the accumulation of DAG (Davis et al., 1986), 
another product of the hydrolysis of PIP2 by phospholipase C, which 
leads to the redistribution of protein kinase C from the cytosol to 
the plasma membrane and to its activation (Naor et al., 1985; McArdle 
et al., 1986). The phorbol ester, TPA, was used to directly activate 
protein kinase C. Forskolin potentiated TPA-stimulated LH release. 
The interaction between forskolin and secretagogues that elevate the 
cytosolic ca2+ concetration was also investigated because ca2+ is an 
important second messenger involved in GnRH stimulation of LH release. 
Agents that allow extracellular ca2+ entry, such as high 
concentrations of K+, veratridine and the ca2+ ionophore, stimulate LH 
release. In this study forskolin potentiated the stimulation of LH 
release by these agents that raise cytosolic ca2+ levels through the 
influx of extracellular C 2+ a . LH release in the presence of B 2+ a , 
which can be substituted for Ca 2+ to stimulate LH release in chicken 
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pituitary cells (Davidson et al., 1987), was also enhanced by 
forskolin. The protein kinase C-dependent pathway and the ca2+ second 
messenger system, when activated simultaneously, interact 
synergistically to stimulate LH release from gonadotropes ( Harris et 
al., 1985; Naor and Eli, 1985; Davidson et al., 1987). Forskolin 
enhanced the synergistic interaction between the ca2+ second messenger 
pathway and the protein kinase C-dependent pathway when these two 
pathways are activated by veratridine and TPA, respectively (Fig.34 ). 
Therefore, the cAMP second messenger pathway, when activated by 
forskolin, is able to interact synergistically with both the protein 
kinase c- 2+ dependent pathway and the Ca second messenger pathway, 
when these pathways are activated individually or simultaneously. 
In conclusion, cAMP may play a direct or at least a modulatory role 
in mediating the action of GnRH. Due to the fact that the anterior 
pituitary consists of a number of different cell types, the slight 
increase in cellular cAMP levels seen due to stimulation of primary 
chicken pituitary cells with GnRH, could be representative of a larger 
increase in cellular cAMP levels within the gonadotropes. Even though 
the change in cellular cAMP levels is small, it could be crucial, 
since only a small change in cellular cAMP levels may be required to 
affect LH release. The site of interaction between forskolin i.e. 
cAMP, and GnRH which results in a synergistic LH response appears to 
be distal to the activation of protein kinase C and the ca2+ second 
messenger pathways. The ability of forskolin to interact 
the protein kinase C-dependent pathway and the ca2+ second 
with both 
messenger 
pathway, in addition to the ability of GnRH to cause a slight increase 
in cellular cAMP levels, suggests that cAMP may play a role in the 
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ability of GnRH to stimulate LH release. 
The role of cAMP and the ca2+ requirements of GnRH-stimulated LH 
release have been investigated. It can be concluded that the GnRH-
stimulated spike phase of LH secretion is independent of ca2+ entry 
via D600/nifedipine-sensitive VSCCs. It is, however, largely 
dependent on extracellular ca2 + that enters via a route that can be 
blocked by RR. The residual portion (about 10%) of the spike phase is 
due to the mobilization of stored intracellular ca2+ as shown by 
kinetic experiments in which the intracellular ca2+ stores were 
depleted. The plateau phase of release is partially dependent (about 
50%) on ca2+ entry via D600- and nifedipine-sensitive VSCCs and on 
ca
2
+ that enters via the major mechanism operative during the spike 
phase which is blocked by RR (about 50%). Thus the ca2+ entry route 
that can be blocked by RR is important in both phases of release and 
may be due to a ROCC or capacitative ca2+ entry. 
The data indicate that ca2+ is the major second messenger pathway 
activated by GnRH. However, cAMP may also be involved in the release 
mechanism but to a lesser extent. Although the generation of DAG and 
its activation of protein kinase C was not examined in this thesis a 
role for DAG as a second messenger involved in GnRH-stimulated LH 
release cannot be excluded. Further investigations should attempt to 
clearly define the role of the protein kinase C second messenger 
pathway in GnRH-stimlated LH release. The advent of cAMP antagonists 
would provide useful tools to understand the role of cAMP as a second 
messenger in this system. 
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